# EDGAR Filing Document

**Accession Number:** 0001821201
**File Stem:** 0001670254-23-000245
**Filing Date:** 2023-3
**Character Count:** 200779
**Document Hash:** 62dc0b3d05cf968366345f1222ccfc7c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001670254-23-000245.hdr.sgml**: 20230317

**ACCESSION NUMBER**: 0001670254-23-000245

**CONFORMED SUBMISSION TYPE**: C

**PUBLIC DOCUMENT COUNT**: 10

**FILED AS OF DATE**: 20230317

**DATE AS OF CHANGE**: 20230316

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bloomi, Inc.
- **CENTRAL INDEX KEY:** 0001821201
- **IRS NUMBER:** 831413180
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-32004
- **FILM NUMBER:** 23740322

**BUSINESS ADDRESS:**
- **STREET 1:** 7970 SURREY LANE
- **CITY:** OAKLAND
- **STATE:** CA
- **ZIP:** 94605
- **BUSINESS PHONE:** 5104105570

**MAIL ADDRESS:**
- **STREET 1:** 7970 SURREY LANE
- **CITY:** OAKLAND
- **STATE:** CA
- **ZIP:** 94605

## Ex-99

### Attached PDF Documents

**Attachment 1:** `document_1.pdf`

# Form C

## Cover Page

Name of issuer:

The Bloomi, Inc.

Legal status of issuer:

Form: Corporation
Jurisdiction of Incorporation/Organization: DE
Date of organization: 2/12/2017

Physical address of issuer:

3987 First Street
Suite K
Livermore CA 94551

Website of issuer:

http://thebloomi.com

Name of intermediary through which the offering will be conducted:

Wefunder Portal LLC

CNI number of intermediary:

0001670254

SEC file number of intermediary:

007-00033

CRD number, if applicable, of intermediary:

283503

Amount of compensation to be paid to the intermediary, whether as a dollar amount or a percentage of the offering amount, or a good faith estimate if the exact amount is not available at the time of the filing, for conducting the offering, including the amount of referral and any other fees associated with the offering.

4.0% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the issuer in connection with the offering.

Any other direct or indirect interest in the issuer held by the intermediary, or any arrangement for the intermediary to acquire such an interest:

No

Type of security offered:

☐ Common Stock
☐ Preferred Stock
☐ Debt
☑ Other

If Other, describe the security offered:

Simple Agreement for Future Equity (SAPE)

Target number of securities to be offered:

100,000

Price:

$1.00000

Method for determining price:

Pro-rated portion of the total principal value of $100,000; interests will be sold in increments of $1 each investment is convertible to one share of stock as described under item 13.

Target offering amount:

$100,000.00

Oversubscriptions accepted:

☑ Yes
☐ No

If yes, disclose how oversubscriptions will be allocated:

☐ Pro-rata basis
☐ First-come, first-served basis
☑ Other

If other, describe how oversubscriptions will be allocated:

As determined by the issuer

Maximum offering amount (if different from target offering amount):

$618,000.00

Deadline to reach the target offering amount:

4/8/2023

NOTE: If the sum of the investment commitments does not equal or exceed the target offering amount at the offering deadline, no securities will be sold in the offering.

Investment commitments will be cancelled and committed funds will be returned.

Current number of employees:

5

|  | Most recent fiscal year-end: | Prior fiscal year-end: |
| --- | --- | --- |
| Total Assets: | $494,107.00 | $30,322.00 |
| Cash & Cash Equivalents: | $133,310.00 | $3,415.00 |
| Accounts Receivable: | $0.00 | $0.00 |
| Short-term Debt: | $157,376.00 | $17,902.00 |
| Long-term Debt: | $450,658.00 | $35,658.00 |
| Reserves/Sales: | $227,069.00 | $166,271.00 |
| Cost of Goods Sold: | $206,747.00 | $131,869.00 |
| Taxes Paid: | $0.00 | $0.00 |
| Net Income: | ($454,758.00) | ($143,158.00) |

Select the jurisdictions in which the issuer intends to offer the securities:

AL, AK, AZ, AR, CA, CO, CT, DE, DC, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY, BS, GU, PR, VI, TV

## Offering Statement

Respond to each question in each paragraph of this part. Set forth each question and any notes, but not any instructions thereto, in their entirety. If disclosure is expected to any question is responsive to one or more other questions, it is not necessary to repeat the disclosure. If a question or series of questions is inapplicable or the response is available elsewhere in the Form, either state that it is inapplicable, include a cross-reference to the responsive disclosure, or omit the question or series of questions.

Be very careful and precise in answering all questions. Give full and complete answers so that they are not misleading under the circumstances involved. Do not discuss any future performance or other anticipated event unless you have a reasonable basis or believe that it will actually occur within the foreseeable future. If any answer requiring significant information is materially inaccurate, incomplete or misleading, the Company, its management and principal shareholders may be liable to investors based on that information.

### THE COMPANY

1. Name of Issuer:

The Bloom, Inc.

### COMPANY ELIGIBILITY

2. ☐ Check this box to certify that all of the following statements are true for the issuer:

- Organized under, and subject to, the laws of a State or territory of the United States or the District of Columbia.
- Not subject to the requirement to file reports pursuant to Section 12 or Section 15(d) of the Securities Exchange Act of 1934.
- Not an investment company registered or required to be registered under the Investment Company Act of 1940.
- Not ineligible to rely on this exemption under Section 4(a)(6) of the Securities Act as a result of a disqualification specified in Rule 503(a) of Regulation Crowdfunding.
- Has filed with the Commission and provided to investors, to the extent required, the ongoing annual reports required by Regulation Crowdfunding during the two years immediately preceding the filing of this offering statement (or for such shorter period that the issuer was required to file such reports).
- Not a development stage company that (a) has no specific business plan or (b) has indicated that its business plan is to engage in a merger or acquisition with an unidentified company or companies.

INSTRUCTION TO QUESTION 2: If any of these statements are not true, then you are NOT eligible to rely on this exemption under Section 4(a)(6) of the Securities Act.

3. Has the issuer or any of its predecessors previously failed to comply with the ongoing reporting requirements of Rule 202 of Regulation Crowdfunding?

☐ Yes ☑ No

### DIRECTORS OF THE COMPANY

4. Provide the following information about each director (and any persons occupying a similar status or performing a similar function) of the issuer:

| Director | Principal Occupation | Main Employee | Year Joined as Director |
| --- | --- | --- | --- |
| Julie Lecterco | Chief Business Officer | Bloomi | 2020 |
| Rebecca Story | CEO | The Bloom, Inc. | 2018 |
| Matthew Story | Marketing Executive | Visa | 2018 |

For three years of business experience, refer to Appendix D: Director & Officer Work History.

### OFFICERS OF THE COMPANY

5. Provide the following information about each officer (and any persons occupying a similar status or performing a similar function) of the issuer:

| Officer | Positions Held | Year Joined |
| --- | --- | --- |
| Julie Lecterco | Chief Business Officer | 2020 |
| Rebecca Story | President | 2018 |
| Rebecca Story | CFO | 2018 |
| Rebecca Story | Secretary | 2018 |
| Rebecca Story | CEO | 2018 |

For three years of business experience, refer to Appendix D: Director & Officer Work History.

INSTRUCTION TO QUESTION 1: For purposes of this Question 1, the term officer means a president, vice president.

secretary, insurance or principal financial officer, companies or principal accounting officer, and any person that conducts performing similar functions.

## PRINCIPAL SECURITY HOLDERS

6. Provide the name and ownership level of each person, as of the most recent practicable date, who is the beneficial owner of 20 percent or more of the issuer's outstanding voting equity securities, calculated on the basis of voting power.

| Name of Holder | No. and Class of Securities Now Held | % of Voting Power Prior to Offering |
| --- | --- | --- |
| Rebecca Story | 8000000.0 Common Stock | 89.73 |

INSTRUCTION REQUESTED: The above information must be provided as of a date that is not more than 120 days prior to the date of filing of this offering statement.

To calculate total voting power, include all securities for which the person directly or indirectly has or shares the voting power, which includes the power to ensure in direct the voting of such securities. If the person has the right to acquire voting power of such securities within 90 days, including through the exercise of any option, warrants or rights, the conversion of a security, or other arrangement, or if securities are held by a member of the funder through compensation or partnerships, or otherwise in a manner that would allow a person to direct or control the voting of the securities (or share in such direction or control - i.e., for example, a no-incentive) they should be included as being 'beneficially insured.' You should include an explanation of these circumstances in a footnote to the 'Number of and Class of Securities Now Held.' To calculate outstanding voting equity securities, assume all outstanding options are exercised and all outstanding convertible securities connected.

## BUSINESS AND ANTICIPATED BUSINESS PLAN

7. Describe in detail the business of the issuer and the anticipated business plan of the issuer.

For a description of our business and our business plan, please refer to the attached Appendix A, Business Description & Plan.

INSTRUCTION REQUESTED: Weynder will provide your company's Weynder profile as an appendix (Appendix A) to the Form C to PDF format. The submission will include all Q&A terms and 'read more' links to an unanticipated format. All values will be transmitted.

This means that any information provided to your Weynder profile will be provided in the SEC or sequence in this question. As a result, your company will be personally liable for misstatements and omissions in your profile under the Securities Act of 1933, which requires you to provide material information related to your business and anticipated business plan. Please review your Weynder profile carefully to ensure it provides all material information, is not false or misleading, and does not omit any information that would cause the information included to be false or misleading.

## RISK FACTORS

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment.

In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document.

The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature.

These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.

8. Discuss the material factors that make an investment in the issuer speculative or risky:

We make consumer goods for purchase. As a result we may be impacted by supply chain interruptions and issues with buying or shipping products.

We are dependent on retailers to sell our product. Our partnership with Target is important to the revenues of the business, and should that partnership be interrupted for any reason our revenues will suffer.

We are operating under the assumption that the intimate Wellness market will continue to expand, and our business will continue to expand with it. Should that market not grow (or reduce for some reason) our growth may be impacted.

The continued growth of our business is reliant on the positive associations that our customers have with our brand. Should our reputation be damaged in any way or the quality of our products be compromised we may lose that positive association and may have difficulty retaining customers.

We operate in a business with historically low margins. Our ability to turn a meaningful profit will be dependent on our ability to increase margins and produce quality products at scale.

The company may use some of the proceeds of the raise to repay debt. The company currently has approximately $500k of debt outstanding.

The Company may never receive a future equity financing or elect to convert the Securities upon such future financing. In addition, the Company may never undergo a liquidity event such as a sale of the Company or an IPO. If neither the conversion of the Securities nor a liquidity event occurs, the Purchasers could be left holding the Securities in perpetuity. The Securities have numerous transfer restrictions and will likely be highly illiquid, with no secondary market on which to sell them. The Securities are not equity interests, have no ownership rights, have no rights to the Company's assets or profits and have no voting rights or ability to direct the Company or its actions.

Our future success depends on the efforts of a small management team. The loss of services of the members of the management team may have an adverse effect on the company. There can be no assurance that we will be successful in attracting and retaining other personnel we require to successfully grow our business.

INSTRUCTION REQUESTED: A brief, periodic assessment and include only those factors that are unique to the issuer. Discussion should be tailored to the issuer's business and the offering and should not repeat the factors addressed in the reports or forfeitures. No specific number of risk factors is required to be identified.

## The Offering

### USE OF FUNDS

9. What is the purpose of this offering?

The Company intends to use the net proceeds of this offering for working capital and annual corporate purposes, which includes the specific items listed in item 10.

and general corporate purposes, which includes the specific items listed in item to below. While the Company expects to use the net proceeds from the Offering in the manner described above, it cannot specify with certainty the particular uses of the net proceeds that it will receive from this Offering. Accordingly, the Company will have broad discretion in using these proceeds.

10. How does the issuer intend to use the proceeds of this offering?

If we issue: $100,000

Use of 35% towards Marketing (professional services and paid ads to grow our DTC presence), 20% towards operations (hiring full time operations person), 41% towards products and COGs, 4% towards Wefunder intermediary fee

If we issue: $618,000

Use of 35% towards Marketing (professional services and paid ads to grow our DTC presence), 20% towards operations (hiring several full time operations, warehouse manager and sales people), 31% towards products and COGs, 4% towards Wefunder intermediary fee, 10% towards debt repayment

Raising the maximum would allow us to accelerate retail expansion, marketing growth and increase product development resources.

INSTRUCTION REQUESTED: 10. An issuer must provide a reasonably detailed description of any intended use of proceeds, such that investors may provided with an adequate amount of information in authorized fees, the offering proceeds will be used. If an issuer has identified a range of possible uses, the issuer should identify and describe each probable use and the factors the issuer may consider in allocating proceeds among the potential uses. If the issuer will accept proceeds in excess of the target offering amount, the issuer must describe the purpose, method for allocating proceeds/options, and intended use of the excess proceeds with similar specificity. Please include all potential uses of the proceeds of the offering, including any that may apply only in the case of execution options. If you do not do so, you may later be required to amend your Form C. Wefunder is not responsible for any failure to you to describe a potential use of offering proceeds.

## DELIVERY & CANCELLATIONS

11. How will the issuer complete the transaction and deliver securities to the investors?

Book Entry and Investment in the Co-issuer. Investors will make their investments by investing in interests issued by one or more co-issuers, each of which is a special purpose vehicle ("SPV"). The SPV will invest all amounts it receives from investors in securities issued by the Company. Interests issued to investors by the SPV will be in book entry form. This means that the investor will not receive a certificate representing his or her investment. Each investment will be recorded in the books and records of the SPV. In addition, investors' interests in the investments will be recorded in each investor's "Portfolio" page on the Wefunder platform. All references in this Form C to an investor's investment in the Company (or similar phrases) should be interpreted to include investments in a SPV.

12. How can an investor cancel an investment commitment?

NOTE: Investors may cancel an investment commitment until 48 hours prior to the deadline identified in these offering materials.

The intermediary will notify investors when the target offering amount has been met. If the issuer reaches the target offering amount prior to the deadline identified in the offering materials, it may close the offering early if it provides notice about the new offering deadline at least five business days prior to such new offering deadline (absent a material change that would require an extension of the offering and reconfirmation of the investment commitment).

If an investor does not cancel an investment commitment before the 48-hour period prior to the offering deadline, the funds will be released to the issuer upon closing of the offering and the investor will receive securities in exchange for his or her investment.

If an investor does not reconfirm his or her investment commitment after a material change is made to the offering, the investor's investment commitment will be cancelled and the committed funds will be returned.

An investor's right to cancel. An investor may cancel his or her investment commitment at any time until 48 hours prior to the offering deadline.

If there is a material change to the terms of the offering or the information provided to the investor about the offering and/or the Company, the investor will be provided notice of the change and must re-confirm his or her investment commitment within five business days of receipt of the notice. If the investor does not reconfirm, he or she will receive notifications disclosing that the commitment was cancelled, the reason for the cancellation, and the refund amount that the investor is required to receive. If a material change occurs within five business days of the maximum number of days the offering is to remain open, the offering will be extended to allow for a period of five business days for the investor to reconfirm.

If the investor cancels his or her investment commitment during the period when cancellation is permissible, or does not reconfirm a commitment in the case of a material change to the investment, or the offering does not close, all of the investor's funds will be returned within five business days.

Within five business days of cancellation of an offering by the Company, the Company will give each investor notification of the cancellation, disclose the reason for the cancellation, identify the refund amount the investor will receive, and refund the investor's funds.

The Company's right to cancel. The Investment Agreement you will execute with us provides the Company the right to cancel for any reason before the offering deadline.

If the sum of the investment commitments from all investors does not equal or exceed the target offering amount at the time of the offering deadline, no securities will be sold in the offering, investment commitments will be cancelled and committed funds will be returned.

Ownership and Capital Structure

# THE OFFERING

13. Describe the terms of the securities being offered.

To view a copy of the SAFE you will purchase, please see

Appendix B, Investor Contracts.

The main terms of the SAFEs are provided below.

The SAFEs. We are offering securities in the form of a Simple Agreement for Future Equity ("SAFE"),

which provides Investors the right to preferred stock in the Company ("Preferred Stock"),

when and if the Company sponsors an equity offering that involves Preferred Stock, on the standard terms offered to other Investors.

Conversion in Preferred Equity. Based on our SAFEs, when we engage in an offering of equity interests involving preferred stock,

Investors will receive a number of shares of preferred stock calculated using the method that results in the greater number of preferred stock:

i. the total value of the Investor's investment, divided by the price of preferred stock issued to new Investors, or

ii. if the valuation for the company is more than $18,000,000.00 (the "Valuation Cap"), the amount invested by the Investor divided by the quotient of

a. the Valuation Cap divided by

b. the total amount of the Company's capitalization at that time.

Additional Terms of the Valuation Cap. For purposes of option (ii) above, "Company Capitalization" means the sum, as of immediately prior to the Equity Financing, of: (1) all shares of Capital Stock (on an as-converted basis) issued and outstanding, assuming exercise or conversion of all outstanding vested and unvested options, warrants and other convertible securities, but excluding (A) this instrument, (B) all other Safes, and (C) convertible promissory notes; and (2) all shares of Common Stock reserved and available for future grant under any equity incentive or similar plan of the Company, and/or any equity incentive or similar plan to be created or increased in connection with the Equity Financing

Liquidity Event. If there is a Liquidity Event before the expiration or termination of this instrument, the Investor will, at its option, either (i) receive a cash payment equal to the Purchase Amount (subject to the following paragraph) or (ii) automatically receive from the Company a number of shares of Common Stock equal to the Purchase Amount divided by the Liquidity Price. If the Investor fails to select the cash option

Liquidity Process. In a Liquidity Event or Dissolution Event, this Safe is intended to operate like standard nonparticipating Preferred Stock. The Investor's right to receive its Cash-Out Amount is:

1. Junior to payment of outstanding indebtedness and creditor claims, including contractual claims for payment and convertible promissory notes (to the extent such convertible promissory notes are not actually or notionally converted into Capital Stock).
2. On par with payments for other Safes and/or Preferred Stock, and if the applicable Proceeds are insufficient to permit full payments to the Investor and such other Safes and/or Preferred Stock, the applicable Proceeds will be distributed pro rata to the Investor and such other Safes and/or Preferred Stock in proportion to the full payments that would otherwise be due; and
3. Senior to payments for Common Stock.

# Securities Issued by the SPV

Instead of issuing its securities directly to investors, the Company has decided to issue its securities to the SPV, which will then issue interests in the SPV to investors. The SPV has been formed by Wefunder Admin, LLC and is a co-issuer with the Company of the securities being offered in this offering. The Company's use of the SPV is intended to allow investors in the SPV to achieve the same economic exposure, voting power, and ability to assert State and Federal law rights, and receive the same disclosures, as if they had invested directly in the Company. The Company's use of the SPV will not result in any additional fees being charged to investors.

The SPV has been organized and will be operated for the sole purpose of directly acquiring, holding and disposing of the Company's securities, will not borrow money and will use all of the proceeds from the sale of its securities solely to purchase a single class of securities of the Company. As a result, an investor investing in the Company through the SPV will have the same relationship to the Company's securities, in terms of number, denomination, type and rights, as if the investor invested directly in the Company.

# Voting Rights

If the securities offered by the Company and those offered by the SPV have voting rights, those voting rights may be exercised by the investor or his or her proxy. The applicable proxy is the Lead Investor, if the Proxy (described below) is in effect.

# Proxy to the Lead Investor

The SPV securities have voting rights. With respect to those voting rights, the investor and his, her, or its transferees or assignees (collectively, the "Investor"), through a power of attorney granted by Investor in the Investor Agreement, has appointed or will appoint the Lead Investor as the Investor's true and lawful proxy and attorney (the "Proxy") with the power to act alone and with full power of substitution, on behalf of the Investor to: (i) vote all securities related to the Company purchased in an offering hosted by Wefunder Portal, and (ii) execute, in connection with such voting power, any instrument or document that the Lead Investor determines is necessary and appropriate in the exercise of his or her authority. Such Proxy will be irrevocable by the Investor unless and until a successor lead investor ("Replacement Lead Investor") takes the place of the Lead Investor. Upon notice that a Replacement Lead Investor has taken the place of the Lead Investor, the Investor will have five (5) calendar days to revoke the Proxy. If the Proxy is not revoked within the 5-day time period, it shall remain in effect.

# Restriction on Transferability

The SPV securities are subject to restrictions on transfer, as set forth in the Subscription Agreement and the Limited Liability Company Agreement of Wefunder SPV, LLC, and may not be transferred without the prior approval of the Company, on behalf of the SPV.

14. Do the securities offered have voting rights?

☐ Yes
☑ No

15. Are there any limitations on any voting or other rights identified above?

See the above description of the Party to the Local Investor.

16. How may the terms of the securities being offered be modified?

Any provision of this Safe may be amended, waived or modified by written consent of the Company and either (i) the Investor or (ii) the majority-in-interest of all then-outstanding Safes with the same Valuation Cap as this Safe, provided that with respect to clause (ii); (A) the Purchase Amount may not be amended, waived or modified in this manner, (B) the consent of the Investor and each holder of such Safes must be solicited (even if not obtained), and (C) such amendment, waiver or modification treats all such holders in the same manner. "Majority-in-interest" refers to the holders of the applicable group of Safes whose Safes have a total Purchase Amount greater than 50% of the total Purchase Amount of all of such applicable group of Safes.

Pursuant to authorization in the Investor Agreement between each Investor and Wefunder Portal, Wefunder Portal is authorized to take the following actions with respect to the investment contract between the Company and an Investor:

1. Wefunder Portal may amend the terms of an investment contract, provided that the amended terms are more favorable to the investor than the original terms; and

2. Wefunder Portal may reduce the amount of an investor's investment if the reason for the reduction is that the Company's offering is oversubscribed.

### RESTRICTIONS ON TRANSFER OF THE SECURITIES BEING OFFERED:

The securities being offered may not be transferred by any purchaser of such securities during the one year period beginning when the securities were issued, unless such securities are transferred:

1. to the issuer;

2. to an accredited investor;

3. as part of an offering registered with the U.S. Securities and Exchange Commission; or

4. to a member of the family of the purchaser or the equivalent, to a trust controlled by the purchaser, to a trust created for the benefit of a member of the family of the purchaser or the equivalent, or in connection with the death or divorce of the purchaser or other similar circumstance.

NOTE: The term "accredited investor" means any person who comes within any of the categories set forth in Rule 501(k) of Regulation D, or who the seller reasonably believes comes within any of such categories, at the time of the sale of the securities to that person.

The term "member of the family of the purchaser or the equivalent" includes a child, stepchild, grandchild, parent, stepparent, grandparent, spouse or spousal equivalent, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law of the purchaser, and includes adoptive relationships. The term "spousal equivalent" means a cohabitant occupying a relationship generally equivalent to that of a spouse.

### DESCRIPTION OF ISSUER'S SECURITIES

17. What other securities or classes of securities of the issuer are outstanding? Describe the material terms of any other outstanding securities or classes of securities of the issuer.

| Class of Security | Securities (or Amount) Authorized | Securities (or Amount) Outstanding | Voting Rights |
| --- | --- | --- | --- |
| Common Stock | 10900000 | 8,916,025 | Yes |

Securities Reserved for Issuance upon Exercise or Conversion

Warrants:

Options:

1983975

Describe any other rights:

The company has not yet authorized Preferred Stock which, if converted as part of an equity financing, investors in the SAFE will receive. Preferred Stock has a liquidation preference over Common Stock.

18. How may the rights of the securities being offered be materially limited, diluted or qualified by the rights of any other class of security identified above?

The holders of a majority-in-interest of voting rights in the Company could limit the Investor's rights in a material way. For example, those interest holders could vote to change the terms of the agreements governing the Company's operations or cause the Company to engage in additional offerings (including potentially a public offering).

These changes could result in further limitations on the voting rights the Investor will have as an owner of equity in the Company, for example by diluting those rights or limiting them to certain types of events or consents.

To the extent applicable, in cases where the rights of holders of convertible debt, SAFES, or other outstanding options or warrants are exercised, or if new awards are granted under our equity compensation plans, an Investor's interests in the Company may be diluted. This means that the pro-rata portion of the Company represented by the Investor's securities will decrease, which could also diminish the Investor's voting and/or economic rights. In addition, as discussed above, if a majority-in-interest of holders of securities with voting rights cause the Company to issue additional equity, an Investor's interest will typically also be diluted.

Based on the risk that an Investor's rights could be limited, diluted or otherwise qualified, the Investor could lose all or part of his or her investment in the securities in this offering, and may never see positive returns.

Additional risks related to the rights of other security holders are discussed below, in Question 20.

19. Are there any differences not reflected above between the securities being offered and each other class of security of the issuer?

☐

10

20. How could the exercise of rights held by the principal shareholders identified in Question 6 above affect the purchasers of the securities being offered?

As holders of a majority-in-interest of voting rights in the Company, the shareholders may make decisions with which the Investor disagrees, or that negatively affect the value of the Investor's securities in the Company, and the investor will have no records to change these decisions. The Investor's interests may conflict with those of other investors, and there is no guarantee that the Company will develop in a way that is optimal for or advantageous to the Investor.

For example, the shareholders may change the terms of the articles of incorporation for the company, change the terms of securities issued by the Company, change the management of the Company, and even force out minority holders of securities. The shareholders may make changes that affect the tax treatment of the Company in ways that are unfavorable to you but favorable to them. They may also vote to engage in new offerings and/or to register certain of the Company's securities in a way that negatively affects the value of the securities the Investor owns. Other holders of securities of the Company may also have access to more information than the Investor, leaving the Investor at a disadvantage with respect to any decisions regarding the securities he or she owns.

The shareholders have the right to redeem their securities at any time. Shareholders could decide to force the Company to redeem their securities at a time that is not favorable to the Investor and is damaging to the Company. Investors' exit may affect the value of the Company and/or its viability.

In cases where the rights of holders of convertible debt, SAFES, or other outstanding options or warrants are exercised, or if new awards are granted under our equity compensation plans, an Investor's interests in the Company may be diluted. This means that the pro-rata portion of the Company represented by the Investor's securities will decrease, which could also diminish the Investor's voting and/or economic rights. In addition, as discussed above, if a majority-in-interest of holders of securities with voting rights cause the Company to issue additional stock, an Investor's interest will typically also be diluted.

21. How are the securities being offered being valued? Include examples of methods for how such securities may be valued by the issuer in the future, including during subsequent corporate actions.

The offering price for the securities offered pursuant to this Form C has been determined arbitrarily by the Company, and does not necessarily bear any relationship to the Company's book value, assets, earnings or other generally accepted valuation criteria. In determining the offering price, the Company did not employ investment banking firms or other outside organizations to make an independent appraisal or evaluation. Accordingly, the offering price should not be considered to be indicative of the actual value of the securities offered hereby.

The initial amount invested in a SAFE is determined by the investor, and we do not guarantee that the SAFE will be converted into any particular number of shares of Preferred Stock. As discussed in Question 13, when we engage in an offering of equity interests involving Preferred Stock, investors may receive a number of shares of Preferred Stock calculated as either (i) the total value of the investor's investment, divided by the price of the Preferred Stock being issued to new investors, or (ii) if the valuation for the company is more than the Valuation Cap, the amount invested divided by the quotient of (a) the Valuation Cap divided by (b) the total amount of the Company's capitalization at that time.

Because there will likely be no public market for our securities prior to an initial public offering or similar liquidity event, the price of the Preferred Stock that investors will receive, and/or the total value of the Company's capitalization, will be determined by our board of directors. Among the factors we may consider in determining the price of Preferred Stock are prevailing market conditions, our financial information, market valuations of other companies that we believe to be comparable to us, estimates of our business potential, the present state of our development and other factors deemed relevant.

In the future, we will perform valuations of our stock (including both common stock and Preferred Stock) that take into account, as applicable, factors such as the following:

- unrelated third party valuations;
- the price at which we sell other securities in light of the relative rights, preferences and privileges of those securities;
- our results of operations, financial position and capital resources;
- current business conditions and projections;
- the marketability or lack thereof of the securities;
- the hiring of key personnel and the experience of our management;
- the introduction of new products;
- the risk inherent in the development and expansion of our products;
- our stage of development and material risks related to our business;
- the likelihood of achieving a liquidity event, such as an initial public offering or a sale of our company given the prevailing market conditions and the nature and history of our business;
- industry trends and competitive environment;
- trends in consumer spending, including consumer confidence;
- overall economic indicators, including gross domestic product, employment, inflation and interest rates; and
- the general economic outlook.

We will analyze factors such as those described above using a combination of financial and market-based methodologies to determine our business enterprise value. For example, we may use methodologies that assume that businesses operating in the same industry will share similar characteristics and that the Company's value will correlate to those characteristics, and/or methodologies that compare transactions in similar securities issued by us that were conducted in the market.

22. What are the risks to purchasers of the securities relating to minority ownership in the issuer?

An Investor in the Company will likely hold a minority position in the Company, and thus be limited as to its ability to control or influence the governance and operations of the Company.

The marketability and value of the Investor's interest in the Company will depend upon many factors outside the control of the Investor. The Company will be managed by its officers and be governed in accordance with the strategic direction and decision-making of its Board Of Directors, and the Investor will have no independent right to name or remove an officer or member of the Board Of Directors of the Company.

Following the Investor's investment in the Company, the Company may sell interests to additional investors, which will dilute the percentage interest of the Investor in the Company. The Investor may have the opportunity to increase its investment in the Company in such a transaction, but such opportunity cannot be assured.

The amount of additional financing needed by the Company, if any, will depend upon the maturity and objectives of the Company. The declining of an opportunity or the inability of the Investor to make a follow-on investment, or the lack of an opportunity to make such a follow-on investment, may result in substantial dilution of the Investor's interest in the Company.

23. What are the risks to purchasers associated with corporate actions, including additional issuances of securities, issuer repurchases of securities, a sale of the issuer or of assets of the issuer or transactions with related parties?

**Additional issuances of securities.** Following the Investor's investment in the Company, the Company may sell interests to additional investors, which will dilute the percentage interest of the Investor in the Company. The Investor may have the opportunity to increase its investment in the Company in such a transaction, but such opportunity cannot be assured. The amount of additional financing needed by the Company, if any, will depend upon the maturity and objectives of the Company. The declining of an opportunity or the inability of the Investor to make a follow-on investment, or the lack of an opportunity to make such a follow-on investment, may result in substantial dilution of the Investor's interest in the Company.

**Issuer repurchases of securities.** The Company may have authority to repurchase its securities from shareholders, which may serve to decrease any liquidity in the market for such securities, decrease the percentage interests held by other similarly situated investors to the Investor, and create pressure on the Investor to sell its securities to the Company concurrently.

**A sale of the issuer or of assets of the issuer.** As a minority owner of the Company, the Investor will have limited or no ability to influence a potential sale of the Company or a substantial portion of its assets. Thus, the Investor will rely upon the executive management of the Company and the Board of Directors of the Company to manage the Company so as to maximize value for shareholders. Accordingly, the success of the Investor's investment in the Company will depend in large part upon the skill and expertise of the executive management of the Company and the Board of Directors of the Company. If the Board Of Directors of the Company authorizes a sale of all or a part of the Company, or a disposition of a substantial portion of the Company's assets, there can be no guarantee that the value received by the Investor, together with the fair market estimate of the value remaining in the Company, will be equal to or exceed the value of the Investor's initial investment in the Company.

**Transactions with related parties.** The Investor should be aware that there will be occasions when the Company may encounter potential conflicts of interest in its operations. On any issue involving conflicts of interest, the executive management and Board of Directors of the Company will be guided by their good faith judgement as to the Company's best interests. The Company may engage in transactions with affiliates, subsidiaries or other related parties, which may be on terms which are not arm's-length, but will be in all cases consistent with the duties of the management of the Company to its shareholders. By acquiring an interest in the Company, the Investor will be deemed to have acknowledged the existence of any such actual or potential conflicts of interest and to have waived any claim with respect to any liability arising from the existence of any such conflict of interest.

24. Describe the material terms of any indebtedness of the issuer:

# **Loss**

| Lender | Maria Alvarez |
| --- | --- |
| Issue date | 10/31/21 |
| Amount | $215,000.00 |
| Outstanding principal plus interest | $215,000.00 as of 02/28/23 |
| Interest rate | 5.0% per annum |
| Current with payments | Yes |

Various maturity dates ranging from November 2021 to March 2024

# **Loss**

| Lender | Rebecca Story |
| --- | --- |
| Issue date | 11/30/21 |
| Amount | $155,000.00 |
| Outstanding principal plus interest | $80,635.00 as of 01/30/23 |
| Current with payments | Yes |

Various interest rates from 0.1% to 10%. Various maturity dates from October 2021 to December 2023

# **Loss**

| Lender | Juan Alvarez Jr |
| --- | --- |
| Issue date | 02/28/22 |
| Amount | $200,000.00 |
| Outstanding principal plus interest | $200,000.00 as of 02/28/23 |
| Interest rate | 5.0% per annum |
| Maturity date | 11/23/23 |
| Current with payments | Yes |

During 2021 the Company entered into a sale of future receivables and merchant cash advance agreement. The Company is advanced the funds on its receivables and the arrangement requires daily repayments on funds subsequently collected. The Company received $15,000 in June 2021 and $25,000 in September 2021. Both advances were paid in full as of December 31, 2021 including fees of $600 and $1,375, respectively.

In December 2021 the received an additional $25,000 and incurred $1,375 in fees. The outstanding balance as of February 2023 is $0.

Notes:

25. What other exempt offerings has the issuer conducted within the past three years?

| Offering Date | Exemption | Security Type | Amount Sold | Use of Proceeds |
| --- | --- | --- | --- | --- |
| 1/2021 | Section 4(a)(2) | SAFE | $469,484 | General operations |
| 2/2022 | Section 4(a)(2) | SAFE | $304,335 | General operations |
| 2/2022 | Section 4(a)(2) | SAFE | $500,000 | General operations |
| 11/2022 | Section 4(a)(2) | SAFE | $671,500 | General operations |
| 12/2022 | Section 4(a)(2) | SAFE | $250,000 | General operations |

26. Was or is the issuer or any entities controlled by or under common control with the issuer a party to any transaction since the beginning of the issuer's last fiscal year, or any currently proposed transaction, where the amount involved exceeds five percent of the aggregate amount of capital raised by the issuer in reliance on Section 4(a)(6) of the Securities Act during the preceding 12-month period, including the amount the issuer seeks to raise in the current offering, in which any of the following persons had or is to have a direct or indirect material interest:

1. any director or officer of the issuer;
2. any person who is, as of the most recent practicable date, the beneficial owner of 20 percent or more of the issuer's outstanding voting equity securities, calculated on the basis of voting power;
3. if the issuer was incorporated or organized within the past three years, any promoter of the issuer;
4. or any immediate family member of any of the foregoing persons.

☑ Yes
☐ No

For each transaction specify the person, relationship to issuer, nature of interest in transaction, and amount of interest.

| Name | Julie Leclercq |
| --- | --- |
| Amount Invested | $10,000.00 |
| Transaction type | Loan |
| Issue date | 10/31/21 |
| Outstanding principal plus interest | $0.00 as of 12/30/22 |
| Interest rate | 5.0% per annum |
| Maturity date | 11/23/23 |
| Relationship | CBO |

| Name | Maria Alvarez |
| --- | --- |
| Amount Invested | $215,000.00 |
| Transaction type | Loan |
| Issue date | 10/31/21 |
| Outstanding principal plus interest | $215,000.00 as of 02/28/23 |
| Interest rate | 5.0% per annum |
| Current with payments | Yes |
| Relationship | Mother of founder |

| Name | Rebecca Story |
| --- | --- |
| Amount Invested | $155,000.00 |
| Transaction type | Loan |
| Issue date | 11/30/21 |
| Outstanding principal plus interest | $80,635.00 as of 01/30/23 |
| Current with payments | Yes |
| Relationship | Founder |

| Name | Juan Alvarez Jr |
| --- | --- |
| Amount Invested | $200,000.00 |
| Transaction type | Loan |
| Issue date | 02/28/22 |
| Outstanding principal plus interest | $200,000.00 as of 02/28/23 |
| Interest rate | 5.0% per annum |
| Maturity date | 11/23/23 |
| Current with payments | Yes |
| Relationship | Founder's brother |

INSTRUCTIONS TO QUESTION 26. The term transaction includes, but is not limited to, any financial transaction, arrangement or relationship (including any indebtedness or guarantee of indebtedness) or any series of similar transactions, arrangements or relationships.

Beneficial ownership for purposes of paragraph (1) shall be determined as of a date that is no more than 120 days prior to the date of filing of the offering, pursuant and using the same calculation described in Question 6 of this Question and Answer format.

The term "number of the family" includes any child, any child, grandchild, parent, assignment, grandparent, spouse or general equivalent, sibling, mother in law, father in law, son in law, daughter in law, brother in law, or sister in law of the person, and includes adoption relationships. The term "spread equivalent" means a calculated occupying a relationship generally equivalent to that of a spouse.

Compare the amount of a related party's interest to any transaction without regard to the amount of the profit or loss involved in the transaction. Where it is not practicable to state the approximate amount of the interest, disclose the approximate amount involved in the transaction.

## FINANCIAL CONDITION OF THE ISSUER

27. Does the issuer have an operating history?

28. Describe the financial condition of the issuer, including, to the extent material, liquidity, capital resources and historical results of operations.

#### Management's Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes and other financial information included elsewhere in this offering. Some of the information contained in this discussion and analysis, including information regarding the strategy and plans for our business, includes forward-looking statements that involve risks and uncertainties. You should review the 'Risk Factors' section for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

#### Overview

Sexologist-led intimacy company making clean products for all bodies.

#### Milestones

The Company was formed as a limited liability company on July 12, 2017. On June 11, 2018, Company converted into a Delaware corporation.

Since then, we have:

- • \$3M in revenue in last 12 months
- • Created over 10 million pleasure moments and counting!
- • Available in over 1,000 Target stores nationwide
- • First Latina-founded brand in Target's sexual wellness aisle
- • \$1.5M raised to date from notable angels and VCs
- • An engaged community of 75k+ social media followers and 10M+ views on TikTok
- • Fast-growing brand in the intimacy market expected to reach \$125B by 2026 (not guaranteed)

#### Historical Results of Operations

- • *Business & Gross Margin*. For the period ended December 31, 2021, the Company had revenues of \$227,369 compared to the year ended December 31, 2020, when the Company had revenues of \$166,271. Our gross margin was 9.07% in fiscal year 2021, compared to 20.69% in 2020.
- • *Assets*. As of December 31, 2021, the Company had total assets of \$494,107, including \$133,310 in cash. As of December 31, 2020, the Company had \$30,322 in total assets, including \$3,416 in cash.
- • *Net Loss*. The Company has had net losses of \$454,758 and net losses of \$143,158 for the fiscal years ended December 31, 2021 and December 31, 2020, respectively.
- • *Liabilities*. The Company's liabilities totaled \$608,034 for the fiscal year ended December 31, 2021 and \$53,560 for the fiscal year ended December 31, 2020.

#### Liquidity & Capital Resources

Refer to Question 26 of this Form C for disclosure of all related party transactions.

To-date, the company has been financed with \$715,000 in debt, \$2,380,319 in SAFEs, and \$65,000 in merchant cash advances.

After the conclusion of this Offering, should we hit our minimum funding target, our projected runway is 18 months before we need to raise further capital.

We plan to use the proceeds as set forth in this Form C under 'Use of Funds'. We don't have any other sources of capital in the immediate future.

We will likely require additional financing in excess of the proceeds from the Offering in order to perform operations over the lifetime of the Company. We plan to raise capital in 15 months. Except as otherwise described in this Form C, we do not have additional sources of capital other than the proceeds from the offering. Because of the complexities and uncertainties in establishing a new business strategy, it is not possible to adequately project whether the proceeds of this offering will be sufficient to enable us to implement our strategy. This complexity and uncertainty will be increased if less than the maximum amount of securities offered in this offering is sold. The Company intends to raise additional capital in the future from investors. Although capital may be available for early-stage companies, there is no guarantee that the Company will receive any investments from investors.

#### Runway & Short/Mid Term Expenses

The Bisoni, Inc. cash in hand is \$350,000, as of January 2023. Over the last three months, revenues have averaged \$200,000/month, cost of goods sold has averaged \$90,000/month, and operational expenses have averaged \$120,000/month, for an average burn rate of \$10,000 per month. Our intent is to be profitable in 10 months.

Since the date our financials cover we have significantly increased revenues and expenses.

We expect our monthly revenue to average about 300K to 500K in the next 3 to 6 months. We expect monthly expenses to be about the same during that period. We expect to do that by investing more money in marketing, and hiring folks to help us scale our operation.

We believe we need to successfully close our entire seed round in order to take us to profitability. We have about \$1M closed of our \$2.5M seed round.

To date, we've been funded primarily through Venture Capital and Angel Investor checks, which includes follow on investment. We already raised a portion of our seed round with these private investors.

All projections in the above narrative are forward-looking and not guaranteed.

INSTRUCTIONS TO QUESTION 29. The discussion must cover each case for which financial statements are provided. For issuers with no prior operating history, the discussion should focus on financial performance and operational liquidity and other challenges. For issuers with an operating history, the discussion should focus on whether historical trends and cash flows are representative of what investors should expect in the future. This was accurate the proceeds of the offering and any other known or pending sources of capital. It was not the proceeds from the offering will affect liquidity, whether involving the or funds and any other additional funds is necessary in the stability of the business, and how quickly the issuer anticipates using its available cash. It is also the other available sources of capital to the business, such as those of credit or required contributions by shareholders. References to the issuer in this Question 29 and these instructions refer to the issuer and its predecessors, if any.

## FINANCIAL INFORMATION

29. Include financial statements covering the two most recently completed fiscal years or the period(s) since inception, if shorter:

Refer to Appendix C, Financial Statements

I, Rebecca Story, certify that:

(1) the financial statements of The Bloom, Inc. included in this Form are true and complete in all material respects; and

(2) the financial information of The Bloom, Inc. included in this Form reflects accurately the information reported on the tax return for The Bloom, Inc. filed for the most recently completed fiscal year.

Rebecca Story
CEO

## STAKEHOLDER ELIGIBILITY

30. With respect to the issuer, any predecessor of the issuer, any affiliated issuer, any director, officer, general partner or managing member of the issuer, any beneficial owner of 20 percent or more of the issuer's outstanding voting equity securities, any promoter connected with the issuer in any capacity at the time of such sale, any person that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with such sale of securities, or any general partner, director, officer or managing member of any such solicitor, prior to May 16, 2016.

(1) Has any such person been convicted, within 10 years (or five years, in the case of issuers, their predecessors and affiliated issuers) before the filing of this offering statement, of any felony or misdemeanor:

- i. In connection with the purchase or sale of any security? ☐ Yes ☑ No
- ii. Involving the making of any false filing with the Commission? ☐ Yes ☑ No
- iii. arising out of the conduct of the business of an underwriter, broker, dealer, municipal securities dealer, investment advisor, funding portal or paid solicitor of purchasers of securities? ☐ Yes ☑ No

(2) Is any such person subject to any order, judgment or decree of any court of competent jurisdiction, entered within five years before the filing of this information required by Section 4A(b) of the Securities Act that, at the time of filing of this offering statement, restrains or entains such person from engaging or continuing to engage in any conduct or practice:

- i. In connection with the purchase or sale of any security? ☐ Yes ☑ No
- ii. Involving the making of any false filing with the Commission? ☐ Yes ☑ No
- iii. arising out of the conduct of the business of an underwriter, broker, dealer, municipal securities dealer, investment advisor, funding portal or paid solicitor of purchasers of securities? ☐ Yes ☑ No

(3) Is any such person subject to a final order of a state securities commission (or an agency or officer of a state performing like functions), a state authority that supervises or examines banks, savings associations or credit unions, a state insurance commission (or an agency or officer of a state performing like functions), an appropriate federal banking agency, the U.S. Commodity Futures Trading Commission, or the National Credit Union Administration that:

- i. at the time of the filing of this offering statement bars the person from:
  - A. association with an entity regulated by such commission, authority, agency or officer? ☐ Yes ☑ No
  - B. engaging in the business of securities, insurance or banking? ☐ Yes ☑ No
  - C. engaging in savings association or credit union activities? ☐ Yes ☑ No
- ii. constitutes a final order based on a violation of any law or regulation that prohibits fraudulent, manipulative or deceptive conduct and for which the order was entered within the 10-year period ending on the date of the filing of this offering statement? ☐ Yes ☑ No

(4) Is any such person subject to an order of the Commission entered pursuant to Section 16(b) or 16B(c) of the Exchange Act or Section 205(a) or (f) of the Investment Advisers Act of 1940 that, at the time of the filing of this offering statement:

- i. suspends or revokes such person's registration as a broker, dealer, municipal securities dealer, investment advisor or funding portal? ☐ Yes ☑ No
- ii. places limitations on the activities, functions or operations of such person? ☐ Yes ☑ No
- iii. bars such person from being associated with any entity or from participating in the offering of any prerey stock? ☐ Yes ☑ No

(5) Is any such person subject to any order of the Commission entered within five years before the filing of this offering statement that, at the time of the filing of this offering statement, orders the person to cease and desist from committing or causing a violation or future violation of:

- i. any scienter-based anti-fraud provision of the federal securities laws, including without limitation Section 17(a)(1) of the Securities Act, Section 10(b) of the Exchange Act, Section 10(c)(1) of the Exchange Act and Section 206(1) of the Investment Advisers Act of 1940 or any other rule or regulation thereunder? ☐ Yes ☑ No
- ii. Section 5 of the Securities Act? ☐ Yes ☑ No

(6) Is any such person suspended or expelled from membership in, or suspended or barred from association with a member of, a registered national securities exchange or a registered national or affiliated securities association for any act or omission to act constituting conduct inconsistent with just and equitable principles of trade?

☐ Yes ☑ No

(7) Has any such person filed (as a registrant or issuer), or was any such person or was any such person named as an underwriter or, any registration statement or Regulation A offering statement filed with the Commission that, within five years before the filing of this offering statement, was the subject of a refusal order, stop order, or order suspending the Regulation A exemption, or is any such person, at the time of such filing, the subject of an investigation or proceeding to determine whether a stop order or suspension order should be issued?

☐ Yes ☑ No

(3) If any such person subject to a United States Postal Service false representation order entered within five years before the filing of the information required by Section 4A(b) of the Securities Act, or in any such person, at the time of filing of this offering statement, subject to a temporary restraining order or preliminary injunction with respect to conduct alleged by the United States Postal Service to constitute a scheme or device for obtaining money or property through the mail by means of false representations?

☐ Yes ☑ No

If you would have answered "Yes" to any of these questions had the conviction, order, judgment, decree, suspension, expulsion or bar occurred or been issued after May 16, 2016, then you are NOT eligible to rely on this exemption under Section 4(a)(3) of the Securities Act.

INSTRUCTIONS TO QUESTION 10: If the order means a written directive or its lawfully submitted (used by a federal or state agency), described in Rule 7(b)(2) of Regulation Crowdfunding, under applicable statutes authority that provides for notice and an opportunity for hearing, which constitutes a final disposition or action by that federal or state agency.

No waivers are required to be disclosed with respect to events relating to any affiliated issuer that occurred before the affiliation errors (the affiliated entity is not) in control of the issuer or (it) under common control with the issuer by a third party that was in control of the affiliated entity at the time of such events.

## OTHER MATERIAL INFORMATION

31. In addition to the information expressly required to be included in this Form, include:

- (1) any other material information presented to investors; and

- (2) such further material information. If any, as may be necessary to make the required statements, in the light of the circumstances under which they are made, not misleading.

The Lead Investor. As described above, each investor that has entered into the Investor Agreement will grant a power of attorney to make voting decisions on behalf of that investor to the Lead Investor (the "Proxy"). The Proxy is irrevocable unless and until a Successor Lead Investor takes the place of the Lead Investor, in which case, the investor has a five (5) calendar day period to revoke the Proxy. Pursuant to the Proxy, the Lead Investor or his or her successor will make voting decisions and take any other actions in connection with the voting on investors' behalf.

The Lead Investor is an experienced investor that is chosen to act in the role of Lead Investor on behalf of Investors that have a Proxy in effect. The Lead Investor will be chosen by the Company and approved by Wefunder Inc. and the identity of the initial Lead Investor will be disclosed to Investors before Investors make a final investment decision to purchase the securities related to the Company.

The Lead Investor can quit at any time or can be removed by Wefunder Inc. for cause or pursuant to a vote of investors as detailed in the Lead Investor Agreement. In the event the Lead Investor quits or is removed, the Company will choose a Successor Lead Investor who must be approved by Wefunder Inc. The identity of the Successor Lead Investor will be disclosed to Investors, and those that have a Proxy in effect can choose to either leave such Proxy in place or revoke such Proxy during a 5-day period beginning with notice of the replacement of the Lead Investor.

The Lead Investor will not receive any compensation for his or her services to the SPV. The Lead Investor may receive compensation if, in the future, Wefunder Advisors LLC forms a fund ("Fund") for accredited investors for the purpose of investing in a non-Regulation Crowdfunding offering of the Company. In such as circumstance, the Lead Investor may act as a portfolio manager for that Fund (and as a supervised person of Wefunder Advisors) and may be compensated through that role.

Although the Lead Investor may act in multiple roles with respect to the Company's offerings and may potentially be compensated for some of its services, the Lead Investor's goal is to maximize the value of the Company and therefore maximize the value of securities issued by or related to the Company. As a result, the Lead Investor's interests should always be aligned with those of investors. It is, however, possible that in some limited circumstances the Lead Investor's interests could diverge from the interests of investors, as discussed in section 8 above.

Investors that wish to purchase securities related to the Company through Wefunder Portal must agree to give the Proxy described above to the Lead Investor, provided that if the Lead Investor is replaced, the Investor will have a 5-day period during which he or she may revoke the Proxy. If the Proxy is not revoked during this 5-day period, it will remain in effect.

Tax Filings. In order to complete necessary tax filings, the SPV is required to include information about each investor who holds an interest in the SPV, including each investor's taxpayer identification number ("TIN") (e.g., social security number or employer identification number). To the extent they have not already done so, each investor will be required to provide their TIN within the earlier of (i) two (2) years of making their investment or (ii) twenty (20) days prior to the date of any distribution from the SPV. If an investor does not provide their TIN within this time, the SPV reserves the right to withhold from any proceeds otherwise payable to the investor an amount necessary for the SPV to satisfy its tax withholding obligations as well as the SPV's reasonable estimation of any penalties that may be charged by the IRS or other relevant authority as a result of the investor's failure to provide their TIN. Investors should carefully review the terms of the SPV Subscription Agreement for additional information about tax filings.

INSTRUCTIONS TO QUESTION 10: If information is presented to investors in a format, media or other means not able to be reflected in text or possible document format, the issuer should include:

(a) a description of the material content of each information;

(b) a description of the format in which such disclosure is presented; and

(c) in the case of disclosure to either, under or other dynamic media or format, a municipal or municipal of such disclosure.

## ONGOING REPORTING

32. The issuer will file a report electronically with the Securities & Exchange Commission annually and post the report on its website, no later than:

120 days after the end of each fiscal year covered by the report.

33. Once needed, the annual report may be found on the issuer's website at:

https://thebloomi.com//invest

The issuer must continue to comply with the ongoing reporting requirements until:

1. the issuer is required to file reports under Exchange Act Sections 13(a) or 15(d);
2. the issuer has filed at least one annual report and has fewer than 300 holders of record;
3. the issuer has filed at least three annual reports and has total assets that do not exceed $10 million;
4. the issuer or another party purchases or repurchases all of the securities issued pursuant to Section 4(a)(6), including any payment in full of debt securities or any complete redemption of redeemable securities, or the issuer liquidates or dissolves in accordance with state law.

## APPENDICES

Appendix A: Business Description & Plan

Appendix B: Investor Contracts

SPV Subscription Agreement
Bloomi SAFE

Appendix C: Financial Statements

Financials 1

Appendix D: Director & Officer Work History

Julie Leclercq
Matthew Story
Rebecca Story
Rebecca Story

Appendix E: Supporting Documents

## Signatures

Intentional misstatements or omissions of facts constitute federal criminal violations. See 18 U.S.C. 1001.

The following documents will be filed with the SEC:

Cover Page XML

Offering Statement (this page)

Appendix A: Business Description & Plan

Appendix B: Investor Contracts

SPV Subscription Agreement

Bloomi SAFE

Appendix C: Financial Statements

Financials 1

Appendix D: Director & Officer Work History

Julie Leclercq

Matthew Story

Rebecca Story

Rebecca Story

Appendix E: Supporting Documents

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100 et seq.), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

The Bloomi, Inc.

By

Rebecca Alvarez Story

Co-Founder and CEO

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100 et seq.), this Form C and Transfer Agent Agreement has been signed by the following persons in the capacities and on the dates indicated.

Julie Leclercq

Co-Founder and CEO
3/3/2023

Rebecca Alvarez Story

Accuett America, Inc.

Co-Founder and CEO

3/3/2023

*The Form C must be signed by the issuer, its principal executive officer or officers, its principal financial officer, its controller or principal accounting officer and at least a majority of the board of directors or persons performing similar functions.*

I authorize Wefunder Portal to submit a Form C to the SEC based on the information I provided through this online form and my company’s Wefunder profile.

As an authorized representative of the company, I appoint Wefunder Portal as the company’s true and lawful representative and attorney-in-fact, in the company’s name, place and stead to make, execute, sign, acknowledge, swear to and file a Form C on the company’s behalf. This power of attorney is coupled with an interest and is irrevocable. The company hereby waives any and all defenses that may be available to contest, negate or disaffirm the actions of Wefunder Portal taken in good faith under or in reliance upon this power of attorney.

**Attachment 2:** `document_2.pdf`

![img-0.jpeg](img-0.jpeg)

## INVEST IN BLOOMI

# Sexologist-led intimacy company making clean products for all bodies

### LEAD INVESTOR

**Kelli Jones**

We are both past and current investors in Bloomi and truly believe in the impact Bloomi's products have on women's sexual health and wellness. In addition, the Bloomi team is stellar with YEARS of experience in this space making them the perfect team to lead this brand. At Sixty8 Capital our thesis is to invest in and support Black and Latinx women-owned companies and brands. We believe in the leadership of Rebecca Alvarez-Story and her team to make Bloomi the #1 brand in the intimacy health and wellness space.

**Invested $250,000 this round & $350,000 previously**

thebloomi.com

Oakland California

Female Founder

Ecommerce

Consumer Goods

Retail

Minority Founder

## Highlights

1

$3M in revenue in last 12 months

2 Created over 10 million pleasure moments and counting!
3 Available in over 1,000 Target stores nationwide
4 First Latina-founded brand in Target's sexual wellness aisle
5 $1.5M raised to date from notable angels and VCs
6 An engaged community of 75k+ social media followers and 10M+ views on TikTok
7 Fast-growing brand in the intimacy market expected to reach $125B by 2026 (not guaranteed)
8 Established industry's first clean standard for intimacy products in the US

## Our Team

![img-1.jpeg](img-1.jpeg)

Rebecca Alvarez Story Co-Founder and CEO

One of the most influential intimacy experts in the country. The UC Berkeley grad has as Master's in Sexology, has led the development of products that have been acquired, and is one of the few Latinas to raise over $2M in venture.

![img-2.jpeg](img-2.jpeg)

Julie Leclercq Co-Founder & CBO

Previously led Partnerships for Orange Silicon Valley, served as Chief of Staff to the CEO, and co-founded the Women in Tech program to support the FemTech industry in San Francisco. Experience leading multiple business units and scaling internationally.

Pitch

# Welcome to Clean Intimate Care

## A BIPOC-owned and sexologist-led intimacy company that is normalizing sexual wellness.

Despite the growing demand for sexual wellness solutions, 95% of intimacy products in the market are made with toxic ingredients and credible sexual education is still lacking.

Bloomi’s purpose is to help millions of people #getinthemood with clean, inclusive, accessible products as well as content that affirms, educates and inspires. We want everyone to make informed decisions about their bodies and enjoy more satisfying sexual and intimate experiences.

## Available at Target!

In March 2022, Bloomi developed a full collection of intimacy products and is the first Latina-led brand to launch a brand in the sexual wellness aisle at Target.

![img-3.jpeg](img-3.jpeg)

![img-4.jpeg](img-4.jpeg)

## THE PROBLEM

![img-5.jpeg](img-5.jpeg)

## People are Craving Connections

Healthy intimate connections are vital to our quality of life, mental health and overall wellness. Yet, 80% of people say they are having unfulfilling intimate experiences.

## Low Libido

One primary driver of this is low libido, which is most often caused by fatigue and high stress. Over one third of people experience low libido and they are searching for natural solutions to improve it. The secondary issue is having little sex education and not knowing where to find clean, simple solutions. However, most product on the market contain toxic ingredients.

## Toxic Products

Products in this category are highly unregulated and can negatively impact health. Most contain ingredients or materials that should not come into contact with intimate skin (e.g. fragrance, glycerin, harsh preservatives) and can cause

## THE SOLUTION

## Bloomi is making intimacy mainstream

![img-6.jpeg](img-6.jpeg)

## The Solution

Clean intimate care

CLEAN

In partnership with top intimacy experts, we created the industry's first and only standard to develop products without toxic materials and ingredients.

INCLUSIVE

Bloomi was founded by a Latino sexual wellness expert, and is led by an inclusive team. Our solutions consider the needs of diverse bodies.

ACCESSIBLE

We've launched plant-based essentials in mass retail (incl. Target) and seamlessly integrate product education into the shopping experience.

Clean

Clean

Bloomi was founded by a Latina sexual wellness expert, and is led by an inclusive team. Our solutions consider the needs of diverse bodies.

# Accessible

We've launched plant-based essentials in mass retail (incl. Target) and seamlessly integrate product education into the shopping experience.

# Essentials Collection

![img-7.jpeg](img-7.jpeg)

![img-8.jpeg](img-8.jpeg)

![img-9.jpeg](img-9.jpeg)

![img-10.jpeg](img-10.jpeg)

![img-11.jpeg](img-11.jpeg)

# Bloomi Essentials

Plant-based intimacy essentials, formulated for all bodies.

Our Essentials collection is a line of clean, plant-based intimate care products for all bodies, that help increase pleasure before, during and after intimate moments.

This accessible line includes six formulas and three devices for consumers who are curious but new to the sexual wellness category. three devices for consumers who are curious but new to the sexual wellness category.

Our Essentials collection is a line of plant-based intimate care products for all bodies, that help increase pleasure before, during and after intimate moments.

This accessible line includes six formulas and three devices for those who are

curious but new to the sexual wellness category.

## Intimate Talk, a Sexology Blog

![img-12.jpeg](img-12.jpeg)

We've partnered with top intimacy experts including sex therapists, sexologists, and physicians to overcome the intimacy crisis as well as cultural taboos about sex. Intimate Talk is an educational destination that normalizes conversations around sex with content that affirms, educates and inspires. Some popular guides include -

*How do you increase sexual satisfaction?*

*How do you master the art of self-seduction?*

*How do you make time for pleasure?*

*How do you choose the best toy(s) for yourself?*

*What intimacy questions to ask your partner on date night?*

# OUR PRODUCTS

![img-13.jpeg](img-13.jpeg)

## Clean Standard

Our products are developed by award-winning intimacy experts including our Co-Founder, Rebecca Alvarez Story. Based on feedback from our community, we create #cleanintimatecare solutions that are extensively tested and made with the highest quality ingredients.

For example, our lubricants are 510(K) cleared by the Food and Drug Administration (FDA), and one of few organic, clean lubricants in the country. Our toys are made with medical-grade silicone, not “body-safe” silicone or other ambiguous terms that don’t disclose the materials.

# Thoughtfully Made

We proudly and intentionally make sustainable, *very* high quality products at accessible price points. Our products are ergonomic, easy-to-use designs that consider various hand sizes, body sizes, and abilities. We also prioritize sustainability and take pride in our eco-friendly packaging which is made with recyclable sugarcane, recyclable plastic, and treeless cartons that are compostable.

# Bilingual

We take great pride in our bilingual (Spanish and English) products. Our labels, packaging and product information are printed in both languages to provide intimacy solutions to an even larger community.

# 5-Star Ratings

Our bestselling collection continually receives high ratings for helping customers explore their bodies, improve intimate connections, and overcome their sexual wellness challenges.

★★★★★

> *Easy to use! The 3 settings were perfect! The sizing is perfect! I love it so much. I cannot wait to try more products from this amazing company. Btw thanks for selling it at Target, sometimes I prefer to see the products in person than online. My expectations are met. Literally it makes my night so much better. It’s me time.*

★★★★★

*I have BCOS and I'm currently in fertility treatments. These things have*

I have PCOS and I'm currently in fertility treatments. These things have caused me to have no libido. For years I have felt like I've lost myself and I will never be able to feel the same way before all these struggles. I feel so lucky to have found this product at Target. It's has changed my intimate life with my husband for the better. I feel like myself again, and the struggles I've had before are behind me. Thank you, a million times thank you.

★★★★★

Hi! Okay so, I'm 26 years old and I've never had an orgasm before this vibrator. I bought it after extensive research, mostly because I loved the color and thought it was the cutest vibrator I'd seen, and I was a big fan of the medical grade, non toxic everything. I care quite a bit about my "little lady" and this was the first time I wasn't nervous about a toy being on/in her.

★★★★★

use lubes because they throw my pH off, but this lube was incredible! It is odorless and so slick that it is barely noticeable. I will be recommending to all of my clients.

# OUR PLAN

## Tailored Experience

Using intimacy products has been shown to increase sexual satisfaction, relax the body, and help you feel happier. In less than a year, Bloomi has created over 10 million pleasure moments with our products.

Our WeFunder campaign we provide the resources to continue this trend by building a system that tailors the shopping and learning experience. We want to help customers build their own sexual wellness routine with personalized

product bundles and custom content recommendations.

Tailored Experience
Intimate health needs are unique to each customer, so we're building a system to customize their experience.
- Recommendations based on individual needs
- Dynamic product pages customized to the visitor
- Seamless integrated system for gathering data
Confidential

# OUR TRACTION

With the capital raised thus far, Bloomi developed and launched our Essentials collection. Since then, we have grown 9x in just one year and are on track to make $69M in the next 4 years (not guaranteed).

Growth Trajectory
Revenue and growth last 12 months
$2.8M
2022 Revenue
9X

Revenue Growth

We've Been Featured in Univision,
Entrepreneur, Glossy, Forbes, and more!

We've Been Featured in Univision,
Entrepreneur, Glossy, Forbes, and more!

Featured On

![img-0.jpeg](img-0.jpeg)

![img-1.jpeg](img-1.jpeg)

WELL + GOOD

![img-2.jpeg](img-2.jpeg)

REFINERY29

![img-3.jpeg](img-3.jpeg)

![img-4.jpeg](img-4.jpeg)

BUSINESS
INSIDER

![img-5.jpeg](img-5.jpeg)

![img-6.jpeg](img-6.jpeg)

![img-7.jpeg](img-7.jpeg)

UNIVISION

![img-8.jpeg](img-8.jpeg)

![img-9.jpeg](img-9.jpeg)

As a Latina-led and wellness brand, our story deeply resonates. We have a community of over 500K across platforms with engagement rates that are 3X the industry average. We've also earned over 40 million media impressions to date.

# Viral Reach

## Viral Reach

*As a Latina-led wellness brand, our story deeply resonates with over 40 million media impressions YTD.*

### PRESS MENTIONS

Hundreds of placements in top tier publications including TV segments, estimated at over 30M impressions.

### VIRAL POSTS

Boost in social reach and exposure, for instance from our 'Latina brand at Target' Tiktok post with 10M views.

![img-10.jpeg](img-10.jpeg)

## THE MARKET

Intimate Wellness is a booming $125B industry with 12.4% CAGR by 2026 with reduced stigma around sex and sexuality driving exponential consumer demand for intimacy solutions. Today you now see several retailers entering the category and VC funding continues to increase every quarter.

# Market Opportunity

A lucrative market still ripe for disruption

![img-11.jpeg](img-11.jpeg)

$125B

Intimacy market size

12.4%

Compound annual growth

Forward looking projections cannot be guaranteed.

The impact of the pandemic has shown that in uncertain times consumers will prioritize wellness and self-care above all else, providing a unique and timely opportunity for us. We anticipate this trend continuing to grow.

## OUR FUTURE

### Getting to $69M

With your investment, we plan to bring high-quality intimacy products to millions of people and are on track to reach $69M in the next four years (not guaranteed).

Growth

75

D

50

![img-12.jpeg](img-12.jpeg)

# Projections

![img-13.jpeg](img-13.jpeg)

Forward looking projections cannot be guaranteed.

![img-14.jpeg](img-14.jpeg)

| Sextys Capital | Melka Hollender |
| --- | --- |
| Josephine Collective | Katherine Castro |
| The Barn Fund | Ana Flores |
| The Sparrow Fund | James Brennan |
| Fab Ventures | Patty Arvelo |
| Pipeline Angels | Vanessa Santos |

# You Can Be Part of Our Growth!

Join our mission to create beautiful intimacy products for all bodies. Together we can create millions of pleasure moments that inspire healthy conversations and build love.

We also believe you should own the companies you love and show with. This is your opportunity to invest, build generational wealth, and be part of a progressive company. Let's do this!

BLOOM

1

build love.

We also believe you should own the companies you love and show with. This is your opportunity to invest, build generational wealth, and be part of a progressive company. Let's do this!

![img-15.jpeg](img-15.jpeg)

**Attachment 3:** `document_3.pdf`

THIS INSTRUMENT AND ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.

# THE BLOOMI, INC.

# SAFE
(Simple Agreement for Future Equity)

THIS CERTIFIES THAT in exchange for the payment by [ENTITY NAME] (the "Investor")
of $[AMOUNT] (the "Purchase Amount") on or about [EFFECTIVE DATE], The Bloomi, Inc., a
Delaware corporation (the "Company"), hereby issues to the Investor the right to certain shares of the Company's capital
stock, subject to the terms set forth below.

The "Valuation Cap" is $18,000,000.

See Section 2 for certain additional defined terms.

# 1. Events

(a) Equity Financing. If there is an Equity Financing before the expiration or termination of this instrument,
the Company will automatically issue to the Investor a number of shares of Safe Preferred Stock equal to the Purchase
Amount divided by the Safe Price.

In connection with the issuance of Safe Preferred Stock by the Company to the Investor pursuant to this Section
1(a), the Investor will execute and deliver to the Company all transaction documents related to the Equity Financing;
provided, that such documents are the same documents to be entered into with the purchasers of Standard Preferred Stock,
with appropriate variations for the Safe Preferred Stock if applicable, and provided further, that such documents have
customary exceptions to any drag-along applicable to the Investor, including, without limitation, limited representations and
warranties and limited liability and indemnification obligations on the part of the Investor.

(b) Liquidity Event. If there is a Liquidity Event before the expiration or termination of this instrument, the
Investor will, at its option, either (i) receive a cash payment equal to the Purchase Amount (subject to the following
paragraph) or (ii) automatically receive from the Company a number of shares of Common Stock equal to the Purchase
Amount divided by the Liquidity Price, if the Investor fails to select the cash option.

In connection with Section (b)(i), the Purchase Amount will be due and payable by the Company to the Investor
immediately prior to, or concurrent with, the consummation of the Liquidity Event. If there are not enough funds to pay the
Investor and holders of other Safes (collectively, the "Cash-Out Investors") in full, then all of the Company's available
funds will be distributed with equal priority and pro rata among the Cash-Out Investors in proportion to their Purchase
Amounts, and the Cash-Out Investors will automatically receive the number of shares of Common Stock equal to the
remaining unpaid Purchase Amount divided by the Liquidity Price. In connection with a Change of Control intended to
qualify as a tax-free reorganization, the Company may reduce, pro rata, the Purchase Amounts payable to the Cash-Out
Investors by the amount determined by its board of directors in good faith to be advisable for such Change of Control to
qualify as a tax-free reorganization for U.S. federal income tax purposes, and in such case, the Cash-Out Investors will
automatically receive the number of shares of Common Stock equal to the remaining unpaid Purchase Amount divided by
the Liquidity Price.

(c) Dissolution Event. If there is a Dissolution Event before this instrument expires or terminates, the Company will pay an amount equal to the Purchase Amount, due and payable to the Investor immediately prior to, or concurrent with, the consummation of the Dissolution Event. The Purchase Amount will be paid prior and in preference to any Distribution of any of the assets of the Company to holders of outstanding Capital Stock by reason of their ownership thereof. If immediately prior to the consummation of the Dissolution Event, the assets of the Company legally available for distribution to the Investor and all holders of all other Safes (the "Dissolving Investors"), as determined in good faith by the Company's board of directors, are insufficient to permit the payment to the Dissolving Investors of their respective Purchase Amounts, then the entire assets of the Company legally available for distribution will be distributed with equal priority and pro rata among the Dissolving Investors in proportion to the Purchase Amounts they would otherwise be entitled to receive pursuant to this Section 1(c).

(d) Termination. This instrument will expire and terminate (without relieving the Company of any obligations arising from a prior breach of or non-compliance with this instrument) upon either (i) the issuance of stock to the Investor pursuant to Section 1(a) or Section 1(b)(ii); or (ii) the payment, or setting aside for payment, of amounts due the Investor pursuant to Section 1(b)(i) or Section 1(c).

# 2. Definitions

"Capital Stock" means the capital stock of the Company, including, without limitation, the "Common Stock" and the "Preferred Stock."

"Change of Control" means (i) a transaction or series of related transactions in which any "person" or "group" (within the meaning of Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), becomes the "beneficial owner" (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of more than 50% of the outstanding voting securities of the Company having the right to vote for the election of members of the Company's board of directors, (ii) any reorganization, merger or consolidation of the Company, other than a transaction or series of related transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction or series of related transactions retain, immediately after such transaction or series of related transactions, at least a majority of the total voting power represented by the outstanding voting securities of the Company or such other surviving or resulting entity or (iii) a sale, lease or other disposition of all or substantially all of the assets of the Company.

"Company Capitalization" means the sum, as of immediately prior to the Equity Financing, of: (1) all shares of Capital Stock (on an as-converted basis) issued and outstanding, assuming exercise or conversion of all outstanding vested and unvested options, warrants and other convertible securities, but excluding (A) this instrument, (B) all other Safes, and (C) convertible promissory notes; and (2) all shares of Common Stock reserved and available for future grant under any equity incentive or similar plan of the Company, and/or any equity incentive or similar plan to be created or increased in connection with the Equity Financing.

"Distribution" means the transfer to holders of Capital Stock by reason of their ownership thereof of cash or other property without consideration whether by way of dividend or otherwise, other than dividends on Common Stock payable in Common Stock, or the purchase or redemption of Capital Stock by the Company or its subsidiaries for cash or property other than: (i) repurchases of Common Stock held by employees, officers, directors or consultants of the Company or its subsidiaries pursuant to an agreement providing, as applicable, a right of first refusal or a right to repurchase shares upon termination of such service provider's employment or services; or (ii) repurchases of Capital Stock in connection with the settlement of disputes with any stockholder.

-2-

"Dissolution Event" means (i) a voluntary termination of operations, (ii) a general assignment for the benefit of the Company's creditors or (iii) any other liquidation, dissolution or winding up of the Company (excluding a Liquidity Event), whether voluntary or involuntary.

"Equity Financing" means a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant to which the Company issues and sells Preferred Stock at a fixed pre-money valuation.

"Initial Public Offering" means the closing of the Company's first firm commitment underwritten initial public offering of Common Stock pursuant to a registration statement filed under the Securities Act.

"Liquidity Capitalization" means the number, as of immediately prior to the Liquidity Event, of shares of Capital Stock (on an as-converted basis) outstanding, assuming exercise or conversion of all outstanding vested and unvested options, warrants and other convertible securities, but excluding: (i) shares of Common Stock reserved and available for future grant under any equity incentive or similar plan; (ii) this instrument; (iii) other Safes; and (iv) convertible promissory notes.

"Liquidity Event" means a Change of Control or an Initial Public Offering.

"Liquidity Price" means the price per share equal to the Valuation Cap divided by the Liquidity Capitalization.

"Safe" means an instrument containing a future right to shares of Capital Stock, similar in form and content to this instrument, purchased by investors for the purpose of funding the Company's business operations.

"Safe Preferred Stock" means the shares of a series of Preferred Stock issued to the Investor in an Equity Financing, having the identical rights, privileges, preferences and restrictions as the shares of Standard Preferred Stock, other than with respect to: (i) the per share liquidation preference and the conversion price for purposes of price-based anti-dilution protection, which will equal the Safe Price; and (ii) the basis for any dividend rights, which will be based on the Safe Price.

"Safe Price" means the price per share equal to the Valuation Cap divided by the Company Capitalization.

"Standard Preferred Stock" means the shares of a series of Preferred Stock issued to the investors investing new money in the Company in connection with the initial closing of the Equity Financing.

# 3. Company Representations

(a) The Company is a corporation duly organized, validly existing and in good standing under the laws of the state of its incorporation, and has the power and authority to own, lease and operate its properties and carry on its business as now conducted.
(b) The execution, delivery and performance by the Company of this instrument is within the power of the Company and, other than with respect to the actions to be taken when equity is to be issued to the Investor, has been duly authorized by all necessary actions on the part of the Company. This instrument constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors' rights generally and general principles of equity. To the knowledge of the Company, it is not in violation of (i) its current certificate of incorporation or bylaws, (ii) any material statute, rule or regulation applicable to the Company or (iii) any material indenture or contract to which the Company is a party or by which it is bound, where, in each case, such violation or default,

-3-

individually, or together with all such violations or defaults, could reasonably be expected to have a material adverse effect on the Company.

(c) The performance and consummation of the transactions contemplated by this instrument do not and will not: (i) violate any material judgment, statute, rule or regulation applicable to the Company; (ii) result in the acceleration of any material indenture or contract to which the Company is a party or by which it is bound; or (iii) result in the creation or imposition of any lien upon any property, asset or revenue of the Company or the suspension, forfeiture, or nonrenewal of any material permit, license or authorization applicable to the Company, its business or operations.
(d) No consents or approvals are required in connection with the performance of this instrument, other than: (i) the Company's corporate approvals; (ii) any qualifications or filings under applicable securities laws; and (iii) necessary corporate approvals for the authorization of Capital Stock issuable pursuant to Section 1.
(e) To its knowledge, the Company owns or possesses (or can obtain on commercially reasonable terms) sufficient legal rights to all patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses, information, processes and other intellectual property rights necessary for its business as now conducted and as currently proposed to be conducted, without any conflict with, or infringement of the rights of, others.

# 4. Investor Representations

(a) The Investor has full legal capacity, power and authority to execute and deliver this instrument and to perform its obligations hereunder. This instrument constitutes valid and binding obligation of the Investor, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors' rights generally and general principles of equity.
(b) The Investor has been advised that this instrument and the underlying securities have not been registered under the Securities Act, or any state securities laws and, therefore, cannot be resold unless they are registered under the Securities Act and applicable state securities laws or unless an exemption from such registration requirements is available. The Investor is purchasing this instrument and the securities to be acquired by the Investor hereunder for its own account for investment, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and the Investor has no present intention of selling, granting any participation in, or otherwise distributing the same. The Investor has such knowledge and experience in financial and business matters that the Investor is capable of evaluating the merits and risks of such investment, is able to incur a complete loss of such investment without impairing the Investor's financial condition and is able to bear the economic risk of such investment for an indefinite period of time.

# 5. Miscellaneous

(a) Any provision of this Safe may be amended, waived or modified by written consent of the Company and either (i) the Investor or (ii) the majority-in-interest of all then-outstanding Safes with the same Valuation Cap as this Safe, provided that with respect to clause (ii): (A) the Purchase Amount may not be amended, waived or modified in this manner, (B) the consent of the Investor and each holder of such Safes must be solicited (even if not obtained), and (C) such amendment, waiver or modification treats all such holders in the same manner. "Majority-in-interest" refers to the holders of the applicable group of Safes whose Safes have a total Purchase Amount greater than \(50\%\) of the total Purchase Amount of all of such applicable group of Safes.
(b) Any notice required or permitted by this instrument will be deemed sufficient when delivered personally or by overnight courier or sent by email to the relevant address listed on their Wefunder account, or 48 hours after being

-4-

deposited in the U.S. mail as certified or registered mail with postage prepaid, addressed to the party to be notified at such party's address listed on their Wefunder account, as subsequently modified by written notice.

(c) The Investor is not entitled, as a holder of this instrument, to vote or receive dividends or be deemed the holder of Capital Stock for any purpose, nor will anything contained herein be construed to confer on the Investor, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at any meeting thereof, or to give or withhold consent to any corporate action or to receive notice of meetings, or to receive subscription rights or otherwise until shares have been issued upon the terms described herein.
(d) Neither this instrument nor the rights contained herein may be assigned, by operation of law or otherwise, by either party without the prior written consent of the other; provided, however, that this instrument and/or the rights contained herein may be assigned without the Company's consent by the Investor to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor; and provided, further, that the Company may assign this instrument in whole, without the consent of the Investor, in connection with a reincorporation to change the Company's domicile.
(e) In the event any one or more of the provisions of this instrument is for any reason held to be invalid, illegal or unenforceable, in whole or in part or in any respect, or in the event that any one or more of the provisions of this instrument operate or would prospectively operate to invalidate this instrument, then and in any such event, such provision(s) only will be deemed null and void and will not affect any other provision of this instrument and the remaining provisions of this instrument will remain operative and in full force and effect and will not be affected, prejudiced, or disturbed thereby.
(f) All rights and obligations hereunder will be governed by the laws of the State of California, without regard to the conflicts of law provisions of such jurisdiction.

(Signature page follows)

-5-

IN WITNESS WHEREOF, the undersigned have caused this instrument to be duly executed and delivered.

**THE BLOOMI, INC.**

By:

Name: Rebecca Story

Title: Chief Executive Officer

Address: 3987 First Street, Unit K
Livermore, CA 94551

**INVESTOR:**

By:

Name: [INVESTOR NAME]

**Attachment 4:** `document_4.pdf`

# **Bloomi I (THE "SPV"),**

a series of Wefunder SPV, LLC, a Delaware limited liability company (the "LLC")

# Subscription Agreement

**[INVESTMENT AMOUNT]**

**[INVESTMENT DATE]**

**Bloomi I** (the "SPV"), a series of Wefunder SPV, LLC (the "LLC"), is a special purpose vehicle that will invest all of its assets in securities issued by **The Bloomi, Inc.** (the "Company"). By making an investment in the SPV through the Wefunder website, I understand and agree to the representations set forth below.

I have reviewed the following information and documents in connection with this Subscription Agreement:

1. The information on the Wefunder website about the Company. I acknowledge that this information was prepared solely by either the Company or a third party whose work has been verified by the Company, and that none of Wefunder, Inc., Wefunder Portal, LLC, Wefunder Admin, LLC or Wefunder Advisors, LLC, nor any of their affiliates, employees or agents, are responsible for the adequacy, completeness, or accuracy of this information;
2. The Form C relating to this investment, which provides information about investment in the Company through the use of the SPV;
3. The Series Appendix, an appendix to the Wefunder SPV, LLC limited liability company agreement (the "**LLC Agreement**"), which sets forth certain specific terms of the SPV;
4. The Terms Appendix, which summarizes the terms of the Company securities to be purchased by the SPV;
5. The LLC Agreement, which sets forth other terms applicable to each SPV;
6. This Subscription Agreement, which sets forth the terms governing your investment in the SPV, and that sets forth certain representations you are making in connection with your investment in the SPV;
7. The Wefunder Investor Agreement; and
8. The Wefunder Terms of Service.

**By making an investment in the SPV through the Wefunder website, I agree to be bound by this Subscription Agreement and the terms of the other agreements listed above with respect to my investment in the SPV.**

# Subscription Agreement

# SCOPE OF AGREEMENT AND INVESTOR ELIGIBILITY
REPRESENTATIONS

A. This agreement ("Agreement") applies to each investment in a series ("SPV") of Wefunder SPV, LLC (the "LLC"). Each series is a separate pool of assets from every other series. Each SPV will invest all of its assets in securities issued by a single company ("Company") as set forth in the applicable series appendix ("Series Appendix") to the Wefunder SPV, LLC limited liability company agreement (LLC Agreement). The terms of the Company securities to be purchased by the SPV are summarized in an appendix ("Terms Appendix") attached to this Agreement.
B. Each SPV is formed by and operated by Wefunder Admin, LLC on behalf of the Company in whose securities that SPV invests.
C. Important information about the Company, about the related SPV, and more generally about investments through the Wefunder website, is available through the Wefunder website. The Investor should review that information, and all relevant Company Information (as defined below), carefully before making an investment in any SPV.
D. Each SPV will offer membership interests ("Interests") in that SPV pursuant to Regulation Crowdfunding under the U.S. Securities Act of 1933, as amended (the "Securities Act").
E. You hereby agree that each time you make an investment in any SPV, you will be deemed to have entered into this Agreement, and will be deemed to have made each representation and covenant contained in this Agreement.
F. Except as the context otherwise requires, any reference in this Subscription Agreement to:

1. a "SPV" shall mean "The LLC acting solely on behalf of and for the account of the SPV";
2. "Investor" and "you" shall mean a person (whether individually, jointly with another person, or through his or her individual retirement account) who has agreed to invest, or has invested, in any SPV; and
3. "Company Information" means:

a. The information on the Wefunder website about the Company. I acknowledge that this information was prepared solely by either the Company or a third party whose work has been verified by the Company, and that neither Wefunder, Inc., Wefunder Portal, LLC, Wefunder Admin, LLC or Wefunder Advisors, LLC (together, the "Wefunder entities," nor any of their affiliates, employees or agents, are responsible for the adequacy, completeness, or accuracy of this information;
b. The Form C relating to this investment, which provides information about investment in the Company through the use of the SPV;
c. The Series Appendix, an appendix to the Wefunder SPV, LLC limited liability company agreement (the "LLC Agreement"), which sets forth certain specific terms of the SPV;
d. The Terms Appendix, which summarizes the terms of the Company securities to be purchased by the SPV;
e. The LLC Agreement, which sets forth other terms applicable to each SPV;
f. This Subscription Agreement, which sets forth the terms governing your investment in the SPV, and that sets forth certain representations you are making in connection with your investment in the SPV;
g. The Wefunder Investor Agreement; and
h. The Wefunder Terms of Service.

INVESTOR'S REPRESENTATIONS AND COVENANTS

# 1. Investor's Review of Information and Investment Decision

1.1. The Investor has carefully read and understands the Company Information. The Investor acknowledges that it has made an independent decision to invest indirectly in the Company through the SPV and that, in making its decision to invest in a SPV, the Investor has relied solely upon the Company Information, any other relevant information on the Wefunder website, and independent investigations made by the Investor. The Investor understands that no representations or warranties have been made to the Investor by the LLC, the relevant SPV, any administrator appointed from time to time with respect to the SPV (the "Administrator"), any lead investor appointed from time to time with respect to the SPV (the "Lead Investor"), or any partner, member, officer, employee, agent, affiliate or subsidiary of any of them regarding the Company.

1.2. The Investor has been provided an opportunity to request additional information concerning the Company and the offering through the Ask A Question feature on wefunder.com.

1.3. The Investor understands and agrees that neither Wefunder, Inc., Wefunder Portal, LLC, Wefunder Admin, LLC, any of their affiliates, nor any director, manager, officer, shareholder, member, employee or agent of Wefunder, Inc., Wefunder Portal, LLC, Wefunder Admin, LLC or any of their affiliates (each, a "Wefunder Party," and collectively, "Wefunder Parties") shall be liable in connection with any information or omission of information contained in materials prepared or supplied by the Company. Such materials may include, but are not limited to, information provided by the Company in the Form C related to the offering, information available through the Wefunder website, and materials distributed to the Investor by the SPV on behalf of a Company.

1.4. The Investor represents and agrees that no Wefunder Party has recommended or suggested any investment in a SPV, or any investment related to a Company, to the Investor.

1.5. Investor understands that no Wefunder Party is an adviser to Investor, and that Investor is not an advisory or other client of any Wefunder Party.

1.6. The Investor is not relying on any Wefunder Party or any other person or entity with respect to the legal, accounting, business, investment, pension, tax or other economic considerations involved in this investment other than the Investor's own advisers that are not affiliated with any of the foregoing persons.

1.7. The Investor has such knowledge and experience in financial and business matters that the Investor is capable of evaluating the merits and risks of the Investor's investment in the SPV and is able to bear such risks. The Investor has obtained, in the Investor's judgment, sufficient information to evaluate the merits and risks of such investment. The Investor has evaluated the risks of investing in the SPV, understands there are substantial risks of loss incidental to the purchase of an Interest and has determined that the Interest is a suitable investment for the Investor and consistent with the general investment objectives of the Investor.

# 2. Investor's Representations Related To Investment in a SPV.

2.1. The Investor is acquiring the Interest for its own account, for investment purposes only and not with an intent to resell or distribute the Interest (or any distributions received from the SPV in whole or in part), and the Investor agrees that it will not sell or otherwise transfer the Interest unless in compliance with Regulation Crowdfunding and other applicable securities laws, and with the terms and conditions of this Agreement.
2.2. The Investor's investment in the Interest is consistent with the investment purposes, objectives and cash flow requirements of the Investor and will not adversely affect the Investor's overall need for diversification and liquidity.
2.3. The Investor has all requisite power, authority and capacity to acquire and hold the Interest and to execute, deliver and comply with the terms of each of the instruments required to be executed and delivered by the Investor in connection with the Investor's subscription for the Interest, including without limitation this Subscription Agreement, and such execution, delivery and compliance does not conflict with, or constitute a default under, any instruments governing the Investor, any law, regulation or order, or any agreement or other undertaking to which the Investor is a party or by which the Investor may be bound. If the Investor is an entity, the person executing and delivering each of such instruments on behalf of the Investor has all requisite power, authority and capacity to execute and deliver such instruments, and, upon request by the SPV, will furnish to the SPV a true and correct copy of any instruments governing the Investor, including all amendments thereto. The signature on each of such instruments is genuine and each of such instruments constitutes a legal, valid and binding obligation of the Investor enforceable against the Investor in accordance with its terms.
2.4. The Wefunder Parties are each hereby authorized and instructed to accept and execute any instructions in respect of the Interest given by the Investor in written or electronic form. The Wefunder Parties may rely conclusively upon and shall incur no liability in respect of any action take upon any notice, consent, request, instructions or other instrument believed in good faith to be genuine or to be signed by properly authorized persons of the Investor.
2.5. Pursuant to the requirements of Treas. Reg. § 301.6109-1(c), the Investor has provided, or agrees to provide upon the earlier of (i) two years of an acquisition of an Interest or (ii) twenty (20) days before any distribution is to be made from the SPV, his, her or its taxpayer identification number (e.g., social security number or employer identification number) under penalties of perjury and has or will attest that the Internal Revenue Service has not notified the Investor that he, she or it is subject to backup withholding.

# 3. The Manager Has The Right To Reject Any Subscription, In Whole Or In Part.

3.1. The Investor understands that the SPV will not register as an investment company under the U.S. Investment Company Act of 1940, as amended (the "Investment Company Act"), nor will it make a public offering of its securities within the United States.
3.2. The Investor understands that the value of all investments in any SPV made through individual retirement accounts ("IRAs") must be less than \(25\%\) of the value of the SPV's assets.

3.3. If the Investor is investing in a SPV through an employee benefit plan of any kind, including an individual retirement account (the "Plan"), and an individual or entity (the "Fiduciary") has entered into this Agreement on behalf of the Plan, the Fiduciary hereby makes the following representations, warranties, and covenants:

i. The Fiduciary is a fiduciary of the Plan who is authorized to invest Plan assets or is acting at the direction of a Plan fiduciary authorized to invest Plan assets. The Fiduciary has determined that an investment in the Fund is consistent with the Fiduciary's responsibilities to the Plan under Employee Retirement Income Security Act of 1974, as amended ("ERISA") or other applicable law, and is qualified to make such investment decision. The Fiduciary is authorized to make all representations, covenants and agreements set forth in this Agreement about and on behalf of the Investor, and the Fiduciary hereby agrees that, except for the representations, covenants and agreements contained in this section 3.3, all representations, covenants and agreements contained in this Agreement are made on behalf of the Investor who is investing through the Plan.

ii. The execution and delivery of this Subscription Agreement, and the investment contemplated hereby has been duly authorized by all appropriate and necessary parties pursuant to the provisions of the instrument or instruments governing the Plan and any related trust; and (B) will not violate, and is not otherwise inconsistent with, the terms of such instrument or instruments.

iii. The Fiduciary acknowledges that the assets of the Fund will be invested in accordance with the Company Information related to that Fund.

iv. The Plan's purchase and holding of an Interest will not constitute a non-exempt transaction prohibited under ERISA, Section 4975 of the Internal Revenue Code (the "Code"), or any similar laws or other federal, state, local, foreign or other laws or regulations applicable to the Plan and its investments. None of the Wefunder entities nor any of their affiliates, agents, or employees: (A) exercises any authority or control with respect to the management or disposition of assets of the Plan used to purchase an Interest; (B) renders investment advice for a fee (pursuant to an agreement or understanding that such advice will serve as a primary basis for investment decisions and that such advice will be based on the particular investment needs of the Plan), with respect to such assets of the Plan, or has the authority to do so, or (C) is an employer maintaining or contributing to, or any of whose employees are covered by, the Plan.

v. The Fiduciary understands and agrees to the fee arrangements described in the Company Information.

vi. The Fiduciary understands and agrees that, to prevent the assets of the SPV from being treated as "plan assets" for purposes of ERISA and Section 4975 of the Code, the Investor may be prohibited from purchasing or acquiring an Interest or may be required to redeem its Interest or a portion thereof.

3.4. The Investor acknowledges that the SPV and any Administrator, on the SPV's behalf, may not accept any investment from an Investor if the Investor cannot truthfully make the representations contained herein.

4. The Correctness And Accuracy Of All Information Provided By Investor To The LLC Or The SPV.

4.1. The Investor confirms that all information and documentation provided to the LLC, the SPV, and any Administrator, including, but not limited to, all information regarding the Investor's identity, taxpayer identification number, the source of the funds to be invested in the SPV, and the Investor's eligibility to invest in offerings under Regulation Crowdfunding, is true, correct and complete. Should any such information change or no longer be accurate, the Investor agrees and covenants that they will promptly notify the Wefunder Parties of such changes via the wefunder.com platform. The Investor agrees and covenants that he, she or it will maintain accurate and up-to-date contact information (including email and mailing address) on the wefunder.com platform and will promptly update such information in the event it changes or is no longer accurate.

4.2. The representations, warranties, agreements, undertakings and acknowledgments made by the Investor in this Subscription Agreement will be relied upon by the LLC, the SPV, and any Administrator in determining the Fund's compliance with federal and state securities laws, and shall survive the Investor's admission as a Member of the SPV.

4.3. All information that the Investor has provided to the LLC, the SPV, and any Administrator concerning the knowledge and experience of financial, tax and business matters of the Investor is correct and complete.

# 5. The Wefunder Parties' Right To Use Investor Information.

5.1. The Investor agrees and consents to the Wefunder Parties, their delegates and their duly authorized agents and any of their respective related, associated or affiliated companies obtaining, holding, using, disclosing and processing the Investor's data:

a. to facilitate the acceptance, management and administration of the Investor's subscription for an Interest on an on-going basis;
b. for any other specific purposes where the Investor has given specific consent to do so;
c. to carry out statistical analysis, market research, and tracking of investment performance over time;
d. to comply with legal or regulatory requirements applicable to the SPV and any Administrator or the Investor, including, but not limited to, in connection with anti-money laundering and similar laws;
e. for disclosure or transfer to third parties including the Investor's financial adviser (where appropriate), regulatory bodies, auditors, technology providers or to the SPV, any Administrator, any Lead Investor, and their delegates or their duly appointed agents and any of their respective related, associated or affiliated companies for the purposes specified above;
1. If the contents thereof are relevant to any issue in any action, suit or proceeding to which the LLC, the SPV, any Administrator, any Lead Investor, or their affiliates are a party or by which they are or may be bound;
g. for other legitimate business of the LLC, the SPV, any Administrator, or any Lead Investor.

5.2. The Investor acknowledges and agrees that it will provide additional information or take such other actions as may be necessary or advisable for the SPV or any Administrator (in the sole judgment of the SPV and/or any Administrator) to comply with any disclosure and compliance policies, related legal process or appropriate requests (whether formal or informal) or otherwise.
5.3. The Investor agrees and consents to disclosure by the LLC, the SPV and any of their agents, including any Administrator or any Lead Investor, to relevant third parties of information pertaining to the Investor in respect of disclosure and compliance policies or information requests related thereto. Without limiting the generality of the foregoing, the Investor agrees that information about the Investor may be provided to the Company in whose securities a SPV will or proposes to invest.
5.4. The Investor authorizes the LLC, the SPV, any Administrator, and each SPV service provider to disclose the Investor's nonpublic personal information to comply with regulatory and contractual requirements applicable to the SPV and its investments. Any such disclosure shall be permitted notwithstanding any privacy policy or similar restrictions regarding the disclosure of the Investor's nonpublic personal information.

# 6. Key Risk Factors

6.1. The Investor understands that investment in a SPV may involve a complete loss of the Investor's investment. In this regard, the Investor understands that such venture investments involve a high degree of risk, and that many or most venture company investments lose money. An Investor may ultimately receive cash, securities, or a combination of cash and securities (and in many cases nothing at all). If the Investor receives securities, the securities may not be publicly traded, and may not have any significant value.
6.2. The Investor understands and agrees that the Interests are subject to restrictions on transfer and cannot be redeemed. Instead, an Investor typically must hold his or her Interest in a SPV until the SPV has sold or otherwise disposed of its investments and the SPV distributes its investments to the investors in the SPV (a "Liquidation Event"). An Investor typically will not receive any distributions until such a Liquidation Event (and may not receive anything even upon a Liquidation Event), which may not occur for many years. The Investor must therefore bear the economic risk of holding their investment for an indefinite period of time.

6.3. The Investor understands and agrees that the Interests: (a) have not been registered under the Securities Act or any other law of the United States, or under the securities laws of any state or other jurisdiction, and therefore an Interest cannot be resold, pledged, assigned or otherwise disposed of unless it is so registered or an exemption from registration is available; and (b) can only be transferred as permitted under Regulation Crowdfunding and subject to the terms and conditions of this Agreement.

6.4. The Investor understands that no guarantees have been made to the Investor about future performance or financial results of the SPV, and an investment in the SPV may result in a gain or loss upon termination or liquidation of the SPV. It is possible that the investors in a SPV will have "phantom income," which could require them to pay taxes on their investment in a SPV even though the SPV does not distribute any income (or does not distribute sufficient income to pay the taxes).

6.5. The Investor understands and agrees that the SPV was formed by and is operated by Wefunder Admin, LLC on behalf of the Company. Investors will have no right to manage or influence the management of any SPV or of the LLC.

6.6. The Investor understands and agrees that the Company may appoint a Lead Investor and that, if appointed, pursuant to a power of attorney granted by the Investor in the Investor Agreement, the Lead Investor will exercise voting authority on behalf of the Investor with respect to the SPV securities the Investor owns.

6.7. The Investor represents that he or she has read and understands the risk factors contained in the Company Information. The Investor understands and agrees that each Company is solely responsible for providing risk factors, conflicts of interest, and other disclosures that investors should consider when investing in securities issued by that Company (including through a SPV), and that the Wefunder Parties have no ability to assure, and have not in any way assured, that any or all such risk factors, conflicts of interest and other disclosures have been presented fully and fairly, or have been presented at all.

6.8. The Investor understands that any privacy statements, reports or other communications regarding the SPV and the Investor's investment in the SPV (including annual and other updates, and tax documents) will be delivered via electronic means, including through wefunder.com. The Investor hereby consents to electronic delivery as described in the preceding sentence. In so consenting, the Investor acknowledges that email messages are not secure and may contain computer viruses or other defects, may not be accurately replicated on other systems, or may be intercepted, deleted or interfered with, with or without the knowledge of the sender or the intended recipient. The Investor also acknowledges that an email from the Wefunder Parties may be accessed by recipients other than the Investor and may be interfered with, may contain computer viruses or other defects and may not be successfully replicated on other systems. No Wefunder Party gives any warranties in relation to these matters.

6.9. The Investor understands and agrees that if he, she or it does not provide a valid taxpayer identification number under penalties of perjury, and attest that the Investor has not been notified by the Internal Revenue Service that he, she or it is subject to backup withholding, the SPV will be required to withhold from any proceeds otherwise payable to the Investor an amount necessary to satisfy the SPV's backup withholding obligations.

6.10. The Investor understands and agrees that if he, she or it does not provide a valid taxpayer identification number to the SPV, the SPV will withhold from any proceeds otherwise payable to the Investor an amount necessary for the SPV to satisfy its tax withholding obligations with respect to such amount. The SPV may also withhold any other amounts representing the SPV's reasonable estimation of penalties that may be charged by the Internal Revenue Service or any other taxing authority as a result of the Investor's failure to provide a valid taxpayer identification number.

# 7. Compliance With Anti-Money Laundering Laws.

7.1. The Investor represents and warrants that the Investor's investment was not directly or indirectly derived from illegal activities, including any activities that would violate U.S. Federal or State laws or any laws and regulations of other countries.

7.2. The Investor acknowledges that U.S. Federal law, regulations and Executive Orders administered by the U.S. Treasury Department's Office of Foreign Assets Control ("OFAC") may prohibit the SPV, any Administrator, or any Lead Investor from, among other things, engaging in transactions with, and the provision of services to, persons on the list of Specially Designated Nationals and Blocked Persons and persons, foreign countries and territories that are the subject of U.S. sanctions administered by OFAC (collectively, the "OFAC Maintained Sanctions").

7.3. The Investor acknowledges that the SPV prohibits the investment of funds by any persons or entities that are (i) the subject of OFAC Maintained Sanctions, (ii) acting, directly or indirectly, in contravention of any applicable laws and regulations, including anti-money laundering regulations or conventions, or on behalf of persons or entities subject to an OFAC Maintained Sanction, (iii) acting, directly or indirectly, for a senior foreign political figure, any member of a senior foreign political figure's immediate family or any close associate of a senior foreign political figure, unless the SPV, after being specifically notified by the Investor in writing that it is such a person, conducts further due diligence, and determines that such investment shall be permitted, or (iv) acting, directly or indirectly, for a foreign shell bank (such persons or entities in (i) - (iv) are collectively referred to as "Prohibited Persons"). The Investor represents and warrants that it is not, and is not acting directly or indirectly on behalf of, a Prohibited Person.

7.4. To the extent the Investor has any beneficial owners, (i) it has carried out thorough due diligence to establish the identities of such beneficial owners, (ii) based on such due diligence, the Investor reasonably believes that no such beneficial owners are Prohibited Persons, (iii) it holds the evidence of such identities and status and will maintain all such evidence for at least five years from the date of the liquidation or termination of the SPV, and (iv) it will make available such information and any additional information requested by the SPV that is required under applicable regulations.

7.5. The Investor acknowledges and agrees that the SPV or any Administrator may "freeze the account" of the Investor, including, but not limited to, by suspending distributions from the SPV to which the Investor would otherwise be entitled, if necessary to comply with anti-money laundering statutes or regulations.

7.6. The Investor acknowledges and agrees that the SPV and/or any Administrator, in complying with anti-money laundering statutes, regulations and goals, may file voluntarily and/or as required by law suspicious activity reports ("SARs") or any other information with governmental and law enforcement agencies that identify transactions and activities that the SPV or any Administrator or their agents reasonably determine to be suspicious, or is otherwise required by law. The Investor acknowledges that the LLC, the SPV, and any Administrator are prohibited by law from disclosing to third parties, including the Investor, any filing or the substance of any SARs.

7.7. The Investor agrees that, upon the request of the LLC, the SPV, or any Administrator, it will provide such information as the LLC, the SPV, or any Administrator requires to satisfy applicable anti-money laundering laws and regulations, including, without limitation, background documentation about the Investor

# 8. Regulatory Provisions

8.1. The Investor understands that no federal or state agency has passed upon the Interests or made any findings or determination as to the fairness of this investment.

8.2. The Investor certifies that the information contained in the executed copy of Form W-9 submitted to the SPV (if any) and/or the taxpayer identification provided to the SPV is correct. The Investor agrees to provide such other documentation as the SPV determines may be necessary for the SPV to fulfill any tax reporting and/or withholding requirements.

8.3. The Investor understands and agrees that the Company may cause the SPV to make an election under Section 754 of the Internal Revenue Code (the "Code") or an election to be treated as an "electing investment partnership" for purposes of Section 743 of the Code. If the SPV elects to be treated as an electing investment partnership, the Investor shall cooperate with the SPV to maintain that status and shall not take any action that would be inconsistent with such election. Upon request, the Investor shall provide the SPV with any information necessary to allow the SPV to comply with (a) its obligations to make tax basis adjustments under Section 734 or 743 of the Code and (b) its obligations as an electing investment partnership.

8.4. The Investor consents to receive any Schedule K-1 (Partner's Share of Income, Deductions, Credits, etc.) from the SPV electronically via email, the Internet and/or another electronic reporting medium in lieu of paper copies. The Investor agrees that it will confirm this consent electronically at a future date in a manner set forth by the Company at such time and as required by the electronic receipt consent rules set forth by the Internal Revenue Service. The Investor may request a paper copy of the Investor's Schedule K-1 by contacting Wefunder Inc. at support@wefunder.com or such other email address as specified on the wefunder.com platform. Requesting a paper copy will not constitute a withdrawal of the Investor's consent to receive reports or other communications, including Schedule K-1, electronically. The Investor may withdraw its consent for electronic delivery or change its contact preferences for such delivery at any time by writing to support@wefunder.com or such other email address as specified on the wefunder.com platform. Such withdrawal will take effect promptly after receipt, unless otherwise agreed upon. Upon receipt of a withdrawal request, the SPV will confirm the withdrawal and the date on which it takes effect in writing (either electronically or on paper). A withdrawal of consent does not apply to a statement that was furnished electronically before the date on which the withdrawal of consent takes effect. The SPV will cease providing information electronically upon termination of the SPV. Notwithstanding the Investor's consent to receive materials electronically, the Investor still may be required to print and attach its Schedule K-1 to a federal, state or local tax return.

# 9. Miscellaneous Provisions

# 9.1. Indemnification

9.1.1. The Investor agrees to indemnify and hold harmless the LLC, the SPV, any Administrator, any Lead Investor, or any partner, member, officer, employee, agent, affiliate or subsidiary of any of them, and each other person, if any, who controls, is controlled by, or is under common control with, any of the foregoing, within the meaning of Section 15 of the Securities Act, and their respective officers, directors, partners, members, shareholders, owners, employees and agents (collectively, the "Indemnified Parties") against any and all loss, liability, claim, damage and expense whatsoever (including all expenses reasonably incurred in investigating, preparing or defending against any claim whatsoever) arising out of or based upon (i) any false representation or warranty made by the Investor, or breach or failure by the Investor to comply with any covenant or agreement made by the Investor, in this Subscription Agreement or in any other document furnished by the Investor to any of the foregoing in connection with this transaction, or (ii) any action for securities law violations instituted by the Investor that is finally resolved by judgment against the Investor.

9.1.2. The Investor also agrees to indemnify each Indemnified Party for any and all costs, fees and expenses (including legal fees and disbursements) in connection with any damages resulting from the Investor's misrepresentation or misstatement contained herein, or the assertion of the Investor's lack of proper authorization from the beneficial owner to enter into this Subscription Agreement or perform the obligations hereof.

9.1.3. The Investor agrees to indemnify and hold harmless each Indemnified Party from and against any tax, interest, additions to tax, penalties, reasonable attorneys' and accountants' fees and disbursements, together with interest on the foregoing amounts at a rate determined by the SPV or any Administrator computed from the date of payment through the date of reimbursement, arising from the failure to withhold and pay over to the U.S. Internal Revenue Service or the taxing authority of any other jurisdiction any amounts computed, as required by applicable law, with respect to the income or gains allocated to or amounts distributed to the Investor with respect to its Interest during the period from the Investor's acquisition of the Interest until the Investor's transfer of the Interest in accordance with this Agreement, the LLC Agreement, and Regulation Crowdfunding.

9.1.4. If for any reason (other than the willful misfeasance or gross negligence of the entity that would otherwise be indemnified) the foregoing indemnification is unavailable to, or is insufficient to hold such Indemnified Party harmless, then the Investor shall contribute to the amount paid or payable by the Indemnified Party as a result of such loss, claim, damage or liability in such proportion as is appropriate to reflect not only the relative benefits received by the Investor on the one hand and the Indemnified Parties on the other but also the relative fault of the Investor and the Indemnified Parties, as well as any relevant equitable considerations.

9.1.5. The reimbursement, indemnity and contribution obligations of the Investor under this section shall be in addition to any liability that the Investor may otherwise have, and shall be binding upon and inure to the benefit of any successors, assigns, heirs and personal representatives of the Indemnified Parties.

9.2. Limitation of Liability. The LLC is a Delaware "multi-series" limited liability company. As a multi-series limited liability company, the LLC may operate multiple series with the benefit of segregation of assets and liabilities among each of its series pursuant to the Delaware Limited Liability Company Act, as amended (the "Delaware Act"). Accordingly, the Investor hereby agrees that the debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a series (including the SPV) shall be enforceable against the assets of that series only and not against the LLC generally or the assets of any other series. In addition, none of the debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to the LLC generally, or any particular series, shall be enforceable against the assets of any other series.

9.3. **Counsel** The Investor understands that Morrison & Foerster LLP serves as legal counsel on certain matters to Wefunder, Inc., Wefunder Portal, LLC, Wefunder Admin, LLC and Wefunder Advisors, LLC and not to the SPV or any Investor by virtue of its investment in the SPV, and that no independent counsel has been retained to represent the SPV or Investors in the SPV. The Investor also understands that Morrison & Foerster LLP has not independently verified any factual assertions made in the Company Information or on the Wefunder website and is not responsible for the SPV's compliance with its investment program or applicable law.

9.4. **Power of Attorney** The Investor hereby appoints each of the Company and Wefunder Admin, LLC as its true and lawful representative and attorney-in-fact, in its name, place and stead to make, execute, sign, acknowledge, swear to and file:

9.4.1. a Certificate of Formation of the LLC and any amendments required under the Delaware Act
9.4.2. the LLC Agreement and any duly adopted amendments;
9.4.3. any and all instruments, certificates and other documents that may be deemed necessary or desirable to effect the winding-up and termination of the LLC or the SPV (including a Certificate of Cancellation of the Certificate of Formation); and
9.4.4. any business certificate, fictitious name certificate, related amendment or other instrument or document of any kind necessary or desirable to accomplish the LLC's or the SPV's business, purpose and objectives or required by any applicable U.S., state, local or other law.

This power of attorney is coupled with an interest, is irrevocable, and shall survive and shall not be affected by the subsequent death, disability, incompetency, termination, bankruptcy, insolvency or dissolution of the Investor; provided, however, that this power of attorney will terminate upon the substitution of another SPV member for all of the Investor's investment in the LLC or the SPV or upon the liquidation or termination of the LLC or the SPV. The Investor hereby waives any and all defenses that may be available to contest, negate or disaffirm the actions of the LLC, the SPV, and any Administrator taken in good faith under this power of attorney.

# 9.5. Confidentiality

9.5.1. The Investor agrees that the Company Information and all financial statements (if any), tax reports (if any), portfolio valuations (if any), private placement memoranda (if any), reviews or analyses of potential or actual investments (if any), reports or other materials prepared or produced by the SPV and/or any Administrator and all other documents and information concerning the affairs of the SPV and/or the Fund's investments, including, without limitation, information about the Company, and/or the persons directly or indirectly investing in the SPV (collectively, the "Confidential Information") that the Investor may receive pursuant to or in accordance with the use of the Wefunder website, an investment in one or more SPVs, or otherwise as a result of its ownership of an Interest in the SPV, constitute proprietary and confidential information about the SPV, any Administrator, and/or any Lead Investor (the "Affected Parties").

9.5.2. The Investor acknowledges that the Affected Parties derive independent economic value from the Confidential Information not being generally known and that the Confidential Information is the subject of reasonable efforts to maintain its secrecy. The Investor further acknowledges that the Confidential Information is a trade secret, the disclosure of which is likely to cause substantial and irreparable competitive harm to the Affected Companies or their respective businesses. The Investor shall not reproduce any of the Confidential Information or portion thereof or make the contents thereof available to any third party other than a disclosure on a need-to-know basis to the Investor's legal, accounting or investment advisers, auditors and representatives (collectively, "Advisers"), except to the extent compelled to do so in accordance with applicable law (in which case the Investor shall promptly notify the SPV of the Investor's obligation to disclose any Confidential Information) or with respect to Confidential Information that otherwise becomes publicly available other than through breach of this provision by the Investor.

9.5.3. To the fullest extent permitted by law, the Investor agrees not to request disclosure or inspection of any such information after the Investor is notified (whether in response to the Investor's request for information or otherwise) that the SPV has determined not to disclose such information.

9.5.4. The Investor agrees that the LLC, the SPV, and the SPV service providers would be subject to potentially irreparable injury as a result of any breach by the Investor of the covenants and agreements set forth in this Item 9.5, and that monetary damages would not be sufficient to compensate or make whole the LLC, the SPV, and the SPV services providers for any such breach. Accordingly the Investor agrees that the LLC, the SPV, and the SPV service providers shall be entitled to equitable and injunctive relief, on an emergency, temporary, preliminary and/or permanent basis, to prevent any such breach or the continuation thereof.

9.6. Amendments. Neither this Subscription Agreement nor any term hereof may be supplemented, changed, waived, discharged or terminated except with the written consent of the Investor and the Company on behalf of the relevant SPV. For the sake of clarity, the restriction on the Company in the preceding sentence applies solely to the form of this Subscription Agreement applicable to SPVs that have had a closing, and does not prevent the Company from changing the form and content of this Subscription Agreement for use in offerings of SPVs that have not had a closing.

9.7. Assignability and Transferability. This Subscription Agreement is not transferable or assignable by the Investor without the prior written consent of the Company on behalf of the SPV, and any transfer or assignment in violation of this provision shall be null and void. The Interests in the SPV being acquired by Investor herein may only be transferred by Investor in compliance with Regulation Crowdfunding and the terms and conditions of this Agreement. If Investor seeks to transfer the Interests, Investor shall first give written notice to the Company and Wefunder Admin, LLC, including the number of Interests that Investor desires to transfer, the proposed price, the name and contact information of the proposed buyer, and any other information that the Company or Wefunder Admin, LLC may reasonably request. To the extent possible, such notice shall be provided through the Wefunder.com website. Any transfer of Interests shall be subject to execution by Investor and the proposed transferee of appropriate documentation, as may be required by the Company or Wefunder Admin, LLC, in their discretion. Investor further acknowledges that pursuant to the LLC Agreement, Wefunder Admin, LLC (as Series Manager of the SPV), may impose additional restrictions on or prohibit the Transfer of Interests for any reason or no reason, in its sole discretion.

9.8. **Repurchase.** In the event that the SPV or any Administrator determines that it is likely that within twelve (12) months the securities of the SPV or the Company will be held of record by a number of persons that would require the SPV or the Company to register a class of its equity securities under the Securities Exchange Act of 1934, as amended ('Exchange Act'), as required by Section 12(g) or 15(d) thereof, the SPV shall have the option to repurchase the Interests from each Investor to the extent necessary to avoid the requirement to register a class of its securities under the Exchange Act. Such repurchase of Interests shall be for the greater of (i) the purchase price of the Interests, or (ii) the fair market value of the Interests, as determined by an independent appraiser of securities chosen by the Administrator. Any such repurchase may only occur with the consent of Wefunder Admin, LLC, as Series Manager of the SPV.

9.9. **Governing Law.** Consent to Jurisdiction. Notwithstanding the place where this Subscription Agreement may be executed by any of the parties hereto, the parties expressly agree that all the terms and provisions hereof shall be construed under the laws of the State of Delaware. Any action or proceeding brought by the SPV or any SPV service provider against one or more investors in the SPV relating in any way to this Subscription Agreement or the LLC Agreement may, and any action or proceeding brought by any other party against the SPV or any SPV service provider relating in any way to this Subscription Agreement or the Company Information shall, be brought and enforced in the state courts of the State of Delaware located in Wilmington or (to the extent subject matter jurisdiction exists therefore) in the courts of the United States located in the District of Delaware; and the Investor and the SPV irrevocably submit to the jurisdiction of both such state and federal courts in respect of any such action or proceeding. The Investor and the SPV irrevocably waive, to the fullest extent permitted by law, any objection that they may now or hereafter have to laying the venue of any such action or proceeding in the courts of the State of Delaware located in Wilmington or in the courts of the United States located in the District of Delaware and any claim that any such action or proceeding brought in any such court has been brought in an inconvenient forum.

9.10. **Severability.** If any provision of this Subscription Agreement is invalid or unenforceable under any applicable law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such applicable law. Any provision hereof that may be held invalid or unenforceable under any applicable law shall not affect the validity or enforceability of any other provisions hereof, and to this extent the provisions hereof shall be severable.

9.11. **Headings.** The headings in this Subscription Agreement are for convenience of reference only, and shall not limit or otherwise affect the meaning hereof.

9.12. **General.** This Subscription Agreement shall be binding upon the Investor and the legal representatives, successors and assigns of the Investor, shall survive the admission of the Investor as a member of a SPV, and shall, if the Investor consists of more than one person, be the joint and several obligation of all such persons.

*[Remainder of page intentionally left blank. Signature page follows.]*

The undersigned have executed this instrument as of the date first above written.

SPV

Bloomi I, as series of Wefunder SPV, LLC
By: Wefunder Admin, LLC, its Manager

By: Founder Signature

Date:

Name: Nicholas Tommarello

Title: Chief Executive Officer

Investor

[INVESTOR NAME]

By: Investor Signature

Date:

CONTACT INFORMATION:

Name: [INVESTOR NAME]

Mailing Address:

City:

Country:

E-mail:

# TERMS APPENDIX FOR THE PURCHASE OF The
Bloomi, Inc. SECURITIES BY Bloomi I. A SERIES OF
WEFUNDER SPV, LLC. A DELAWARE LIMITED
LIABILITY COMPANY

**Type of Security:** Future Equity

**Terms** $18M valuation cap

To view a copy of the contract, please see **Appendix B, Investor Contracts** of
the Form C. The latest Form C or C/A filing be found here:
https://www.sec.gov/cgi-bin/srch-edgar?text=%28FORM-
TYPE%3DC%2FA+or+FORM-
TYPE%3DC%29+and+CIK%3D0001821201&first=2016

**Attachment 5:** `document_5.pdf`

# **The Bloomi Inc.**

(a Delaware Corporation)

# **Unaudited Financial Statements**

Period of January 1, 2020 through

December 31, 2021

Reviewed by:

![img-0.jpeg](img-0.jpeg)

TaxDrop LLC
A New Jersey CPA Company

FS-2

# Financial Statements

# The Bloomi Inc.

# Table of Contents

| Independent Accountant's Review Report | FS-3 |
| --- | --- |
| Financial Statements and Supplementary Notes |  |
| Balance Sheet as of December 31, 2021 and December 31, 2020 | FS-4 |
| Income Statement for the period of January 1, 2020 through December 31, 2021 | FS-5 |
| Statement of Changes in Stockholders' Equity for the period of January 1, 2020 through December 31, 2021 | FS-6 |
| Statement of Cash Flows for the period of January 1, 2020 through December 31, 2021 | FS-7 |
| Notes and Additional Disclosures to the Financial Statements as of December 31, 2021 and December 31, 2020 | FS-8 |

FS - 3

## Independent Accountant’s Review Report

January 27, 2023

**To:** Management of The Bloomi Inc.

**Attn:** Julie Leclercq, Co-Founder

**Re:** 2021-2020 Financial Statement Review- The Bloomi Inc.

### Financial Review of the Financial Statements

We have reviewed the accompanying financial statements of The Bloomi Inc. (the “Company”), which comprise the balance sheet as of December 31, 2021 and December 31, 2020 and the related statements of income, equity, and cash flows for the period of January 1, 2020 through December 31, 2021, and the related notes to the financial statements. A review includes primarily applying analytical procedures to management’s financial data and making inquiries of company management. A review is substantially limited in scope compared to an audit, the objective of which is the expression of an opinion regarding the financial statements as a whole. Accordingly, we do not express such an opinion.

#### Management’s Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of these financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement whether due to fraud or error.

#### Accountant’s Responsibility

Our responsibility is to conduct the review engagement in accordance with Statements on Standards for Accounting and Review Services promulgated by the Accounting and Review Services Committee of the AICPA. Those standards require us to perform procedures to obtain limited assurance as a basis for reporting whether we are aware of any material modifications that should be made to the financial statements for them to be in accordance with accounting principles generally accepted in the United States of America. We believe that the results of our procedures provide a reasonable basis for our conclusion.

#### Accountant’s Conclusion

Based on our review, we are not aware of any material modifications that should be made to the accompanying financial statements of The Bloomi Inc. for them to be in accordance with accounting principles generally accepted in the United States of America.

Sincerely,

*TaxDrop LLC*

TaxDrop LLC  
Robbinsville, New Jersey  
January 27, 2023

FS - 4

# **The Bloomi, Inc.**  
 **BALANCE SHEETS**  
 **December 31, 2021 and 2020**  
 **(Unaudited)**

|  | (Restated) |  |
| --- | --- | --- |
| ASSETS | 2021 | 2020 |
| Current Assets |  |  |
| Cash and cash equivalents | $133,310 | $3,416 |
| Inventory | 318,082 | 26,906 |
| Prepaid expenses | 14,432 | - |
| Total Current Assets | 465,825 | 30,322 |
| Property and Equipment |  |  |
| Product molds | 28,282 | - |
| Accumulated depreciation | - | - |
| Net Property and Equipment | 28,282 | - |
| Total Assets | $494,107 | $30,322 |
| LIABILITIES AND STOCKHOLDERS' EQUITY |  |  |
| Current Liabilities |  |  |
| Accounts payable | $24,717 | $ - |
| Accrued expenses | 5,939 | 9,589 |
| Deferred revenue | 14,160 | 2,075 |
| Accrued interest | 4,926 | 942 |
| Current portion of notes payable | 85,000 | 3,933 |
| Due to Wayflyer | 21,315 | - |
| Total Current Liabilities | 157,376 | 17,902 |
| Long-Term Liabilities |  |  |
| Notes payable, net of current portion | 450,658 | 35,658 |
| Total Long-Term Liabilities | 450,658 | 35,658 |
| Total Liabilities | 608,034 | 53,560 |
| Stockholders' equity |  |  |
| Common Stock, $0.0001 par value; 10,000,000 authorized; 8,916,025 shares issued and outstanding | 892 | 892 |
| Additional Paid in Capital | 1,624 | 1,624 |
| Stock subscription receivable | - | (1,600) |
| Additional Paid In Capital - SAFEs | 657,107 | 295,000 |
| Additional Paid in Capital - Stock Options | 6,374 | 6,012 |
| Retained Earnings/ (Accumulated Deficit) | (779,924) | (325,166) |
| Total Stockholders' Equity | (113,927) | (23,238) |
| Total Liabilities and Stockholders' Equity | $494,107 | $30,322 |

The accompanying footnotes are an integral part of these financial statements.

FS - 5

# **The Bloomi, Inc.**  
 **INCOME STATEMENTS**  
 **For the Years Ended December 31, 2021 and 2020**  
 **(Unaudited)**

|  | 2021 | 2020 |
| --- | --- | --- |
| Revenues, net of discounts and refunds | $227,369 | $166,271 |
| Cost of Goods Sold | 206,747 | 131,869 |
| Gross Profit | 20,623 | 34,402 |
| Operating Expenses |  |  |
| Advertising and marketing | 80,670 | 69,116 |
| Product development | 77,531 | 6,367 |
| General and administrative | 60,074 | 22,190 |
| Salaries and wages | 172,897 | 65,454 |
| Rent | 1,750 | - |
| Professional services | 77,881 | 6,846 |
| Depreciation and amortization | - | - |
| Total Operating Expenses | 470,804 | 169,973 |
| Other Income |  |  |
| Interest expense | (4,215) | (1,740) |
| Stock based compensation | (362) | (5,846) |
| Total Other income (expense) | (4,577) | (7,586) |
| Net Income (Loss) | (454,758) | $(143,158) |

The accompanying footnotes are an integral part of these financial statements.

FS - 6

# The Bloomi, Inc.

# STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

# For the Years Ended December 31, 2021 and 2020

# (Unaudited)

|  | Common Stock |  |  | Stock Subscription Receivable | Additional Paid in Capital - SAFEs | Additional Paid in Capital - Stock Options | Retained Earnings/ (Accumulated Deficit) | Total Stockholders' Equity (Deficit) |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  | Shares | Value ($ par) | Additional Paid in Capital |  |  |  |  |  |
| Balance as of December 31, 2019, as previously stated | 8,900,400 | $890 | $ - | $ - | $165,000 | $166 | $(182,098) | $(16,042) |
| Prior period adjustment (Note 10) | (900,000) | (90) | - | - | - | - | 90 | - |
| Balance as of December 31, 2019 as restated | 8,000,400 | 800 | - | - | 165,000 | 166 | (182,008) | (16,042) |
| Issuance of Common Stocks | 915,625 | 92 | 1,624 | (1,600) | - | - | - | 116 |
| Issuance of SAFE Notes | - | - | - | - | 130,000 | - | - | 130,000 |
| Stock based compensation | - | - | - | - | - | 5,846 | - | 5,846 |
| Net loss | - | - | - | - | - | - | (143,158) | (143,158) |
| Balance as of December 31, 2020 | 8,916,025 | 892 | 1,624 | (1,600) | 295,000 | 6,012 | (325,166) | (23,238) |
| Issuance of Common Stocks | - | - | - | - | - | - | - | - |
| Receipt of subscription receivable | - | - | - | 1,600 | - | - | - | 1,600 |
| Issuance of SAFE Notes | - | - | - | - | 362,107 | - | - | 362,107 |
| Stock based compensation | - | - | - | - | - | 362 | - | 362 |
| Net loss | - | - | - | - | - | - | (454,758) | (454,758) |
| Balance as of December 31, 2021 | 8,916,025 | $892 | $1,624 | $ - | $657,107 | $6,374 | $(779,924) | $(113,927) |

The accompanying footnotes are an integral part of these financial statements.

FS - 7

# **The Bloomi, Inc.**  
 **STATEMENTS OF CASH FLOWS**  
 **For the Years Ended December 31, 2021 and 2020**  
 **(Unaudited)**

|  | 2021 | 2020 |
| --- | --- | --- |
| Cash Flows from Operating Activities |  |  |
| Net Income (Loss) | $(454,758) | $(143,158) |
| Adjustments to reconcile net income (loss) to net cash provided by operations: |  |  |
| Depreciation and amortization | - | - |
| Accrued interest | 3,985 | 942 |
| Stock based compensation | 362 | 5,846 |
| Changes in operating assets and liabilities: |  |  |
| Inventory | (291,176) | (20,783) |
| Prepaids | (14,432) | - |
| Accounts payable | 24,717 | - |
| Accrued expenses | (3,694) | (1,798) |
| Deferred revenue | 12,086 | 2,075 |
| Net cash provided by (used in) operating activities | (722,912) | (155,513) |
| Cash Flows from Investing Activities |  |  |
| Purchase of product molds | (28,282) | - |
| Net cash used in investing activities | (28,282) | - |
| Cash Flows from Financing Activities |  |  |
| Repayments on notes payable | - | (24,362) |
| Proceeds from notes payable issuance | 496,067 | 20,000 |
| Issuance of SAFEs | 362,107 | 130,000 |
| Issuance of Common Stock | - | 116 |
| Receipt of Stock subscription receivable | 1,600 | - |
| Net borrowings from Wayflyer | 21,315 | - |
| Net cash used in financing activities | 881,088 | 125,754 |
| Net change in cash and cash equivalents | 129,894 | (29,758) |
| Cash and cash equivalents at beginning of period | 3,416 | 33,174 |
| Cash and cash equivalents at end of period | $133,310 | $3,416 |

The accompanying footnotes are an integral part of these financial statements.

FS 8

# **THE BLOOMI INC.**  
**NOTES TO FINANCIAL STATEMENTS**  
**AS OF DECEMBER 31, 2021 AND 2020**

# **NOTE 1 - NATURE OF OPERATIONS**

The Bloomi, Inc. (which may be referred to as the “Company,” “we,” “us,” or “our”) is an e-commerce marketplace that offers a variety of intimate care products for women. The Company was formed as a limited liability company on July 12, 2017. On June 11, 2018, Company converted into a Delaware corporation. The Company began operations in 2017.

Since inception, the Company has relied on contributions from owners, the issuance of Simple Agreement for Future Equity (“SAFE”) and notes payable to fund its operations. As of December 31, 2021, the Company had an accumulated deficit and will likely incur additional losses prior to generating positive retained earnings. During the next twelve months, the Company intends to fund its operations with funding from a crowdfunding campaign (see Note 11), issuance of SAFEs (see Note 11), and funds from revenue producing activities.

Management believes the actions discussed above are probable of occurring and alleviate the substantial doubt raised by our historical operating results and satisfy the liquidity needs 12 months from the issuance of these financial statements.

# **NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, who is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements.

# **Basis of Accounting**

The accounting and reporting policies of the Company conform to accounting principles generally accepted in the United States of America (“US GAAP”). Any reference in these notes to applicable guidance is meant to refer to U.S. GAAP as found in the Accounting Standards Codification (“ASC”) and Accounting Standards Updates (“ASU”) of the Financial Accounting Standards Board (“FASB”).

# **Use of Estimates**

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results could materially differ from these estimates. It is reasonably possible that changes in estimates will occur in the near term.

Significant estimates inherent in the preparation of the accompanying financial statements include valuation of provision for refunds and chargebacks, and stock-based compensation expense.

# **Risks and Uncertainties**

The Company has a limited operating history. The Company’s business and operations are sensitive to general business and economic conditions in the United States. A host of factors beyond the Company’s control could cause fluctuations in these conditions. Adverse conditions may include recession, downturn or otherwise, local competition or changes in consumer taste. These adverse conditions could affect the Company’s financial condition and the results of its operations.

FS 9

# **THE BLOOMI INC.**
**NOTES TO FINANCIAL STATEMENTS**
**AS OF DECEMBER 31, 2021 AND 2020**

# **Concentration of Credit Risk**

The Company maintains its cash with a major financial institution located in the United States of America, which it believes to be credit worthy. The Federal Deposit Insurance Corporation insures balances up to $250,000. At times, the Company may maintain balances in excess of the federally insured limits.

# **Cash and Cash Equivalents**

The Company considers short-term, highly liquid investment with original maturities of three months or less at the time of purchase to be cash equivalents. Cash consists of funds held in the Company's checking account.

# **Inventory**

Inventories are stated at the lower of cost or market value. Cost is determined by the first-in, first out method.

# **Prepaid Expenses**

Prepaid expenses are capitalized expenses with a service period that extends beyond year end. Such expenses are capitalized and recognized straight-line over the useful life, typically one year.

# **Fixed Assets**

Property and equipment are recorded at cost. Expenditures for renewals and improvements that significantly add to the productive capacity or extend the useful life of an asset are capitalized. Expenditures for maintenance and repairs are charged to expense. When equipment is retired or sold, the cost and related accumulated depreciation are eliminated from the accounts and the resultant gain or loss is reflected in income.

Depreciation is provided using the straight-line method, based on useful lives of the assets.

Product molds were placed into service during 2023; therefore no depreciation has been recognized for the year ended December 31, 2021.

The Company reviews the carrying value of property and equipment for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable from the estimated future cash flows expected to result from its use and eventual disposition. In cases where undiscounted expected future cash flows are less than the carrying value, an impairment loss is recognized equal to an amount by which the carrying value exceeds the fair value of assets. The factors considered by management in performing this assessment include current operating results, trends and prospects, the manner in which the property is used, and the effects of obsolescence, demand, competition, and other economic factors. Based on this assessment there was no impairment for the years ended December 31, 2021 and 2020.

# **Fair Value Measurements**

US GAA defines fair value as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price) and such principles also establish a fair value hierarchy that prioritizes the inputs used to measure fair value using the following definitions (from highest to lowest priority):

- Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.
- Level 2 - Observable inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data by correlation or other means.
- Level 3 - Prices or valuation techniques requiring inputs that are both significant to the fair value measurement and unobservable.

FS - 10

# **THE BLOOMI INC.**  
**NOTES TO FINANCIAL STATEMENTS**  
**AS OF DECEMBER 31, 2021 AND 2020**

There were no assets or liabilities requiring fair value measurement as of December 31, 2021 and 2020.

### Income Taxes

The Company is taxed as a “C” Corporation. Income taxes are provided for the tax effects of transactions reporting in the financial statements and consist of taxes currently due plus deferred taxes related primarily to differences between the basis of receivables, property and equipment, intangible assets, and accrued expenses for financial and income tax reporting.

The deferred tax assets and liabilities represent the future tax return consequences of those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The Company evaluates its tax positions that have been taken or are expected to be taken on income tax returns to determine if an accrual is necessary for uncertain tax positions. As of December 31, 2021, the unrecognized tax benefits accrual was zero. The Company will recognize future accrued interest and penalties related to unrecognized tax benefits in income tax expense if incurred.

The Company has filed its income tax return for the period ended December 31, 2021, which will remain subject to examination by the Internal Revenue Service under the statute of limitations for a period of three years from the date it is filed.

### Revenue Recognition

The Company adopted the requirements of the new guidance of ASC Topic 606, *Revenue from Contracts with Customers*, on January 1, 2020, utilizing the modified retrospective method of transition. Adoption of the new guidance resulted in no significant changes to the amount or the Company’s accounting policies for revenue recognition, trade and other receivable, contract cost, contract liabilities, and deferred costs.

Revenue is recognized when performance obligations under the terms of the contracts with our customers are satisfied. The Company generates revenues by offering products on the Bloomí website, where orders are fulfilled via drop-shipping. The Company’s payments are generally collected upfront. Deferred revenue represents payment for sales where orders paid for have yet to ship to customers. Deferred revenue is expected to be earned in the subsequent 12 months and therefore considered a current liability. The Company’s sales are earned and recognized at a single point in time when the order has been shipped.

### Accounts Receivable

Trade receivables due from customers are uncollateralized customer obligations due under normal trade terms. Trade receivables are stated at the amount billed to the customer. Payments of trade receivables are allocated to the specific invoices identified on the customer’s remittance advice or, if unspecified, are applied to the earliest unpaid invoices. As of December 31, 2021 and 2020 the company had no accounts receivable.

The Company estimates an allowance for doubtful accounts based upon an evaluation of the current status of receivables, historical experience, and other factors as necessary. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change.

### Advertising

The Company expenses advertising costs as they are incurred.

### Stock Based Compensation

FS - 11

# **THE BLOOMI INC.**  
 **NOTES TO FINANCIAL STATEMENTS**  
 **AS OF DECEMBER 31, 2021 AND 2020**

Stock based compensation expense reflects the fair value of equity-based awards that have vested at the end of the reporting period and is remeasured at the end of every reporting period.

# **Recent Accounting Pronouncements**

In February 2016, FASB issued ASU No. 2016-02, *Leases*, that requires organizations that lease assets, referred to as 'lessees', to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases with lease terms of more than 12 months. ASU 2016-02 will also require disclosures to help investors and other financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases and will include qualitative and quantitative requirements. The new standard for nonpublic entities will be effective for fiscal years beginning after December 15, 2021. We are currently evaluating the effect that the updated standard will have on the financial statements and related disclosures.

The FASB issues ASUs to amend the authoritative literature in ASC. There have been a number of ASUs to date, including those above, that amend the original text of ASC. Management believes that those issued to date either (i) provide supplemental guidance, (ii) are technical corrections, (iii) are not applicable to us or (iv) are not expected to have a significant impact on our financial statements.

# **NOTE 3 - INVENTORY**

Inventory consisted of the following as of December 31, 2021 and 2020:

|  | 2021 | 2020 |
| --- | --- | --- |
| Finished Goods | $57,653 | $26,906 |
| Purchase Order Deposits | 260,429 | - |
| Total Inventory | $318,082 | $26,906 |

# **NOTE 4 - INCOME TAXES**

The ultimate realization of net deferred tax assets is dependent upon the generation of sufficient future taxable income. The following deferred tax assets and liabilities assume a 21% tax rate

Deferred tax assets as of December 31, 2021, as summarized as follows:

| Deferred tax assets: | $124,636 |
| --- | --- |
| Deferred tax liabilities: | (0) |
| Less: Valuation allowance | (124,636) |
| Deferred tax assets, net | $0 |

The ultimate realization of net deferred tax assets is dependent upon the generation of sufficient future taxable income in the applicable tax jurisdictions. In assessing the realizability of the deferred tax assets, the Company considered all positive and negative evidence available for all relevant jurisdictions and determined that it is more likely than not that all of the deferred tax assets will not be realized. The Company's cumulative losses since inception represent sufficient negative evidence to require a full valuation allowance in 2021. The Company will maintain a valuation allowance until sufficient positive evidence exists to support its reversal.

On December 31, 2021, the Company has federal net operating loss carryforwards of $593,504. As a result of the 2017 Tax Cuts and Jobs Act, federal net operating losses generated for tax years starting after December 31, 2017, have an indefinite life. The tax attributes such as net operating loss and tax credit carryforwards may be subject to Internal Revenue Code Section 382 change of ownership limitations, which have not been determined as of December

FS - 12

# THE BLOOMI INC.
NOTES TO FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2021 AND 2020

31, 2021. As such, the federal net operating loss totaling $593,504 has an indefinite carry forward life.

# NOTE 5 - DUE TO WAYFLYER

During 2021 the Company entered into a sale of future receivables and merchant cash advance agreement. The Company is advanced the funds on its receivables and the arrangement requires daily repayments on funds subsequently collected. The Company received $15,000 in June 2021 and $25,000 in September 2021. Both advances were paid in full as of December 31, 2021 including fees of $600 and $1,375, respectively.

In December 2021 the received an additional $25,000 and incurred $1,375 in fees. The outstanding balance as of December 31, 2021 was $21,315 and was repaid in full subsequent to year end.

# NOTE 6 - NOTES PAYABLE

In January 2020, the Company entered into a loan for $20,000 with total interest of $3,600. The loan was paid off in February 2021. The balance of the loan as of December 31, 2020 was $3,933.

During 2020 the Company received $11,005 in advances from a shareholder under and ongoing advance agreement. In 2021 the Company received $12,381 in net advances from the shareholder under the ongoing advance agreement.

During 2021 the Company issued $505,000 in notes payable agreements with various terms. The following table details the note payable agreement details.

| From | Amount | Origination Date | Maturity Date | Interest Rate | Balance December 31, 2021 | Balance December 31, 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Shareholder #1 | $50,000 | October 19, 2021 | October 19, 2023 | 10% | $50,000 | $ - |
| Shareholder #1 | $10,000 | December 23, 2021 | December 23, 2023 | 5% | $10,000 | $ - |
| Shareholder #1 | $100,000 | December 29, 2021 | December 29, 2023 | 10% | $100,000 | $ - |
| Shareholder #1 Advance Agreement | Various | December 31, 2018 | November 5, 2023 | 0.18% | $30,658 | $35,658 |
| Investor #1 | $100,000 | November 9, 2021 | November 9, 2023 | 5% | $100,000 | $ - |
| Investor #1 | $100,000 | November 23, 2021 | November 23, 2023 | 5% | $100,000 | $ - |
| Investor #2 | $50,000 | October 22, 2021 | October 22, 2023 | 5% | $50,000 | $ - |
| Investor #2 | $85,000 | December 17, 2021 | December 17, 2022 | 5% | $85,000 | $ - |
| Shareholder #2 | $10,000 | November 23, 2021 | November 23, 2023 | 5% | $10,000 | $ - |

Future principal repayments are approximately as follows for the years ending December 31,

| 2022 | $85,000 |
| --- | --- |
| 2023 | 450,658 |
| Thereafter | - |
| Total future principal payments | $535,658 |

Accrued interest on all note agreements as of December 31, 2021 and 2020 was $4,926 and $942, respectively.

FS - 13

# **THE BLOOMI INC.**  
 **NOTES TO FINANCIAL STATEMENTS**  
 **AS OF DECEMBER 31, 2021 AND 2020**

# **NOTE 7 - ADDITIONAL PAID-IN CAPITAL - SAFEs**

The Company has issued SAFEs totaling $657,107. The SAFEs are automatically convertible into SAFE Preferred Stock on the completion of an equity financing with the principal purpose of raising capital (“Qualified Financing”).

| Amount | Valuation Cap | Pre-money or Post Money | Discount Rate |
| --- | --- | --- | --- |
| $150,000 | $8,000,000 | Pre-money | 23% |
| $35,000 | $8,000,000 | Pre-money | 10% |
| $177,107 | $6,000,000 | Pre-money | 15% |
| $295,000 | $6,000,000 | Post-money | 15% |

The conversion price is the lesser of the price per share of Stock received by the Company in a Qualified Financing less the discount rate or the price per share equal to the quotient of a pre-money or post-money valuation at the valuation cap divided by the aggregate number of shares of the Company’s cap table outstanding immediately prior to the initial closing of a Qualified Financing assuming full conversion or exercise of outstanding stock options and Notes. As the conversion and the resulting effect of the discount on the price per share is not calculable until a Qualified Financing event occurs, there is currently no amount recorded related to the discount.

# **NOTE 8 - STOCK BASED COMPENSATION**

The Company has a 2019 stock compensation plan (“the Plan”) which permits the grant or option of shares to its employees for up to 2,099,600 shares of common stock. The Company believes that such awards will help the Company attract, retain and motivate its management and other persons, including officers, directors, key employees and certain consultants, will encourage and reward such persons’ contributions to the performance of the Company and will align their interests with the interests of the Company’s stockholders.

As of December 31, 2021, the Company has issued options to purchase 1,258,975 shares of common stock at an exercise price between $0.0001-$0.04 per share. The options vest subject performance or over time with a 2 to 4-year period. As of December 31, 2021 and 2020, shares vested totaled 331,305 and 311,667, respectively.

Total stock-based compensation expense to be recognized for all awards as of December 31, 2021 and 2020 was $17,046 for both years. The Company recognized stock option compensation expense for shares vesting during December 31, 2021 and 2020 totaling $362 and $5,846, respectively. As of December 31, 2021, $10,672 of stock-based compensation was unearned.

# **NOTE 9 - COMMITMENTS AND CONTINGENCIES**

The Company is not currently involved with and does not know of any pending or threatening litigation against the Company.

# **COVID 19**

In January 2020, the World Health Organization has declared the outbreak of a novel coronavirus (COVID-19) as a “Public Health Emergency of International Concern,” which continues to spread throughout the world and has adversely impacted global commercial activity and contributed to significant declines and volatility in financial markets. The coronavirus outbreak and government responses are creating disruption in global supply chains and adversely impacting many industries. The outbreak could have a continued material adverse impact on economic and market conditions and trigger a period of global economic slowdown. The rapid development and fluidity of this situation precludes any prediction as to the ultimate material adverse impact of the coronavirus outbreak. Nevertheless, the outbreak presents uncertainty and risk with respect to the Company, its performance, and its financial results.

FS - 14

# **THE BLOOMI INC.**  
**NOTES TO FINANCIAL STATEMENTS**  
**AS OF DECEMBER 31, 2021 AND 2020**

# **NOTE 10 - PRIOR PERIOD ADJUSTMENT**

During 2020 it was discovered that an agreement to repurchase shares was recorded incorrectly. As a result, Common stock at par value totaling $90 was overstated and accumulated deficit was understated by $90. Shares issued and outstanding was overstated by 900,000 shares. The accompanying 2020 financial statements have been restated to reflect the correction of this error.

# **NOTE 11 - SUBSEQUENT EVENTS**

# **Issuance of SAFEs**

As of January 27, 2023 the Company has issued additional SAFEs totaling $1,775,835, of which $304,335 has a $10,000,000 valuation cap (post-money) with no discount. Amounts totaling $500,000 have a $10,000,000 valuation cap (post-money) with a 20% discount. Amounts totaling $971,500 have a valuation cap of $15,000,000 with no discount.

# **Additional Loans**

In March 2022 the Company issued a note payable for $100,000 bearing interest at 5% and maturing March 17, 2024. In August 2022 the Company issued a note payable for $100,000 bearing interest at 5% and maturing December 31, 2022.

# **Crowdfunded Offering**

The Company intends to offer up to $1,235,000 in SAFEs (the “Crowdfunded Offering”). The Company is attempting to raise a minimum amount of $25,000 in this offering. The Company must receive commitments from investors totaling the minimum amount by the offering deadline listed in the Form C, in order to receive any funds.

# **Management’s Evaluation**

Management has evaluated subsequent events through January 27, 2023, the date the financial statements were available to be issued. Based on this evaluation, no additional material events were identified which require adjustment or disclosure in the financial statements.

**Attachment 6:** `document_6.pdf`

## Coordonnées

www.linkedin.com/in/julieleclercq (LinkedIn)

## Principales compétences

Strategic Partnerships

Sourcing New Business

Cross-functional Team Leadership

## Languages

Français (Native or Bilingual)

Anglais (Full Professional)

Italien (Elementary)

Allemand (Elementary)

## Publications

Téléréalité, Unité et Diversité

# Julie Leclercq-Argueta

Co-Founder at Bloomi | Startup Lover | Business Development & Partnerships Person | Former Chief of Staff | Forbes Next 1000 Nominee

Région de Washington DC-Baltimore

## Résumé

Julie is co-Founder at Bloomi, the trusted destination for Clean Intimate CareTM, where she oversees business operations and community building.

Prior to that, Julie led Partnerships for Orange Silicon Valley where she supported portfolio startups in their international growth, connecting them to C-level executives from various corporations and VC firms. She also served as Chief of Staff to the CEO and co-founded the Women in Tech program, a community of members who support the FemTech industry in San Francisco.

She has worked with global brands in community building, business development, and partnerships roles in the media industry including Maison Moderne in Luxembourg and My Little Paris in France (acquired in 2017).

Julie holds a Bachelor’s degree in Political Sciences and a Master’s degree in Marketing and Market Research from Sciences Po Paris, a leading Political Science university, where she graduated Cum Laude. She also holds a certification in Computer Science from the University of Berkeley California.

## Expérience

Bloomi

Co-Founder

février 2020 - Present (3 ans 2 mois)

San Francisco Bay Area

Bloomi is the trusted destination for Clean Intimate CareTM. We offer inclusive content and developed clean intimate care essentials for all bodies.

Page 1 of 4

- Our team launched the first and only clean standard in the intimate care industry
- We mindfully developed 11 clean intimate care products that incite discovery and exploration
- We are available on Bloomi's website and at Target
- We are featured in 50+ media publications including Forbes, Well+Good, Cosmo, Beauty Independent and more.

# Orange Silicon Valley

6 ans

# Chief Of Staff, PMO

février 2019 - février 2020 (1 an 1 mois)

San Francisco Bay Area

PMO to the CEO office:

- Drove cross-unit collaboration, project coordination and execution of strategy
- Prepared keynote presentations and briefing documents for external meetings and executive visits
- Manage detailed planning of OKRs and KPIs
- Assisted CEO in discussions and decision-making process

# Business Development & Partnerships Lead

novembre 2018 - février 2020 (1 an 4 mois)

San Francisco Bay Area

- Developed and oversaw Orange's corporate partnership program, connecting key enterprise stakeholders (from Total, Unilever, Bureau Veritas & more) to local startups and investors

- Led the business development initiative to foster partnerships between Orange Fab portfolio startups and Orange business units, external corporate partners, VCs and CVCs

- Supported startups in their growth and interactions with executives.

Troubleshoot potential roadblocks

- Co-founded a Women in Tech program: a community of 200+ members who support each other and exchange perspectives on topics such as healthcare, education or wellness.

Orange Silicon Valley (OSV) is the Bay Area presence of Orange, one of the world's leading telecommunication operators, serving 265 million customers

Page 2 of 4

across 29 countries. OSV engages with the regional Silicon Valley ecosystem through numerous programs, such as Orange Fab (startup program), Fab Force, and Orange Digital Ventures.

#### Business Development Manager

janvier 2016 - novembre 2018 (2 ans 11 mois)

San Francisco Bay Area

#### Business Analyst

2014 - décembre 2015 (1 an)

San Francisco Bay Area

#### Maison Moderne

##### Digital Business Development Manager

mars 2013 - décembre 2013 (10 mois)

Luxembourg, Luxembourg

Maison Moderne is Luxembourg's first independent business media outlet, committed to Luxembourg's modernisation and international standing.

- Managed the digital business unit for Maison Moderne's advertising entity with a team of 2 traffic managers and 10 sales experts.

#### Le Nouvel Observateur

##### Business Development Associate

septembre 2012 - septembre 2013 (1 an 1 mois)

Paris Area, France

- Developed and managed custom brand content products (including articles, videos, infographics, events and beyond on print, web, mobile) for agencies and brands on various media channels including L'Obs (best-selling news magazine in France), Obsession, Rue89 and Challenges

- Analyzed results and the advertising market environment to optimize future campaigns

> Internship turned into a full time position

#### Vila Bea

##### Business Development Associate

février 2013 - juillet 2013 (6 mois)

Morocco

Supported the launch of Vila Bea's hotel through:

Page 3 of 4

- Market research
- Website development (content & architecture)
- CRM, SEO and advertising recommendations
- Community management
- Distribution channels partnerships

My Little Paris

Account Manager Assistant (acquired for 90M)

juin 2012 - janvier 2013 (8 mois)

Paris Area, France

- Supported large clients such as Fiat, Lancel, and Longchamp in deploying their custom advertising campaigns on My Little Paris' websites
- Analyzed campaign results and online behaviors to optimize website performance

L.K.Bennett

International Business Development Assistant

septembre 2010 - juin 2011 (10 mois)

London, United Kingdom

Assistant to the International Sales Director:

- Assisted international wholesale customers in Paris, Milan, Düsseldorf, London alongside the sales director
- Managed orders and sales
- Contributed to visual merchandising

# Formation

UC Berkeley Extension

Certification, Computer Science · (2018 - 2019)

Sciences Po

Master's degree, Marketing and Market Research · (2008 - 2014)

Sciences Po

Bachelor's degree, Social Sciences · (2008 - 2011)

Page 4 of 4

**Attachment 7:** `document_7.pdf`

Contact

www.linkedin.com/in/mattestory
(LinkedIn)

Top Skills

Digital Marketing
Digital Strategy
Customer Insight

Certifications

Black Executive Leadership Program

# Matt Story

Global Brand Partnerships & Advocacy Programs @ Visa, ex:
Procter & Gamble, Intel, Publicis Groupe | AFROTECH Executive
Changemaker | What's Your Story? Podcast Host | Investor
Oakland, California, United States

## Summary

I am a midwest-born mama's boy that was adopted by California
and never moved back. As a husband to a successful entrepreneur
wife, proud #GirlDad, podcast host, investor and curious marketer,
I spend most of my days focused on my personal mission of being
a consistent force that enables my tribe to be better and creating
a more inclusive and equitable world. In my down time, I enjoy all
things related to Peloton, Basketball, and Sneakers.

At Visa, I lead our global efforts to create brand partnerships and
advocacy programs. I utilize my 20+ years of client and agency
experience leading multi-faceted teams to create, scale and execute
collaborative marketing initiatives and programs that uplift key
stakeholders and underserved communities.

As a host of What's Your Story? podcast, I sit with BIPOC leaders to
learn how they have used their unique lived experience to develop
superpowers that make our world a better place. I'm a fan of stories
and enjoy learning how I can improve myself from their experiences.

Things you should message me about: Potential brand partnerships,
opportunities to collaborate on advocacy initiatives/programs
supporting small business owners/financial inclusion/sustainability,
speaking opportunities related to marketing/inclusive leadership/
advocacy, being a guest on my podcast, or anything Peloton/
Basketball/Sneaker related.

## Experience

Visa

9 years 2 months

Vice President, Global Brand Partnerships & Advocacy
February 2021 - Present (2 years 2 months)

Page 1 of 4

San Francisco, California, United States

Matt is currently Vice President, Global Brand Partnerships & Advocacy at Visa where he leads the organizations strategy for marketing partnerships and approach to uplifting underrepresented audiences through marketing initiatives.

Senior Director, Global Marketing

February 2014 - February 2021 (7 years 1 month)

San Francisco Bay Area

What's Your Story? Podcast

Podcast Host

June 2020 - Present (2 years 10 months)

Oakland, California, United States

In this podcast, he explores the personal origin stories of BIPOC leaders that have blazed a new trail to become a success. Matt brings his love of storytelling to amplify how his guests utilized their diverse experience to make an impact on the world. If you are ready to turn your background into a superpower but don't have a plan, this podcast is for you. If you would like to support diverse, equitable and inclusive communities, this podcast is for you. If you are just a fan of stories, this podcast is for you.

the Bloomi

Investor/Board of Directors

September 2017 - Present (5 years 7 months)

Oakland, California

Bloomi is an intimate wellness brand and online retailer that carries hygiene, period and sexual wellness items and created the first Clean Standard in the industry.

Intel Media

Senior Digital Marketing Lead

June 2013 - February 2014 (9 months)

Santa Clara, CA

Responsible for marketing strategy across owned digital properties. Worked across multi-functional internal and external teams to represent the brand across all consumer touch points in digital ecosystem. Developed consumer insights based on digital behaviors that impacted marketing, product and business decisions.

Razorfish

Page 2 of 4

# VP Strategy

January 2012 - June 2013 (1 year 6 months)

Los Angeles, CA

Responsible for digital strategy identifying unique insights and actionable recommendations that help clients drive business growth and competitive advantage. Assignments represent various engagements such as digital ecosystem development, strategic business justifications, multi-platform experience strategies, and new product entry.

# Denuo, a Publicis Groupe Company

VP, Director

April 2007 - January 2012 (4 years 10 months)

Responsible for group's center of expertise across mobile, collaboration and gaming practices that service direct clients and other sister-agency clients. Manage and lead development of campaigns focused on utilizing the whitespaces of marketing that allow clients to "see around the corner" and solve marketing challenges. Lead new business development and strategic growth for Western Region. Experience in building relationships and providing thought leadership for multiple client sectors highlighted by companies such as AstraZeneca, General Mills, General Electric, General Motors, Hyundai, Microsoft, PNC Bank, Procter & Gamble, Purina, and Square Enix. Contributor of strategic perspectives on the in-game advertising industry to clickZ.com from 2008-2009 (http://www.clickz.com/author/profile/1128/matt-story).

# Play, division of Denuo Group

Associate Director

October 2006 - April 2007 (7 months)

Lead priority client accounts including General Motors and Procter & Gamble. Orchestrated Virtual NCAA Final 4 program for Pontiac that broke through the March Madness clutter with unique content delivering branded messaging. Received industry recognition from MIXX and MI6. Awarded industry Rising Star in 2007 by OMMA.

# Procter & Gamble

Interactive Marketing/Business Analyst Manager

June 2002 - September 2006 (4 years 4 months)

Delivered innovative programs that introduced beauty care category brands to in-game advertising within core and casual games, directly increasing brand consideration and purchase intention. Created custom solution for business team to approximate all outlet business results overcoming Walmart's lack of

Page 3 of 4

sharing results. Managed programs that introduced beauty category to digital platforms such as instant messaging, in-game integration and social media. Launched company's first-ever consumer-facing blog for Secret Sparkle Body Spray.

## Education

Washington University in St. Louis

Bachelor of Science, Computer Science & Computer

Engineering · (1998 - 2002)

Page 4 of 4

**Attachment 8:** `document_8.pdf`

Contact

www.linkedin.com/in/rebeccastory
(LinkedIn)
www.rebeccaalvarezstory.com/
(Personal)

Top Skills

Clinical Research
Clinical Trials
Regulatory Affairs

Languages

English (Native or Bilingual)
Spanish (Native or Bilingual)

Honors-Awards

Forbes Next 1000, 2021 Well +
Good Changemaker

# Rebecca Alvarez Story (she/
her/ella)

Co-Founder, Bloomi | Sexologist | Speaker
San Francisco Bay Area

# Summary

Rebecca Alvarez Story is the Co-Founder and CEO of Bloomi, a
sexologist-led intimacy company.

As a nationally sought-after sexologist, entrepreneur, and speaker,
she is now helping to normalize sexual wellness in the US and
Mexico by creating accessible, clean intimacy products and inclusive
content with Bloomi. Rebecca is one of the few Latinas in the US to
raise over $2M in venture capital and in 2022, led the first Latina-
founded brand to launch nationwide in the sexual wellness aisle in
over 1000 Target stores.

Rebecca has been featured and contributes to publications including
Forbes, Well+Good, Parents Latina, Byrdie, Refinery29, Elite Daily,
BeLatina, mitú and more. She has been named a Changemaker by
Well+Good and Forbes' Next 1000. As a proud daughter of Latine
immigrants, Rebecca also focuses on diversity initiatives that elevate
other BIPOC in entrepreneurship.

Prior to Bloomi, Rebecca designed and led a variety of clinical
research projects across medical devices, IVD and consumer
products. She has a proven track record of bringing products to
market with successful management and execution of clinical studies
and sought-after expertise in building intimacy products.

Rebecca earned her BA in Women's Health & Sexuality, a major she
created, from UC Berkeley, and her MA in Sexology.

Rebecca currently resides in the Bay Area with her husband and two
daughters.

# Experience

Page 1 of 2

## Bloomi

### Co-Founder & CEO

July 2018 - Present (4 years 9 months)

Oakland, CA

Bloomi is a sexologist-led intimacy company.

## Self-employed

### Sexologist

September 2011 - Present (11 years 7 months)

San Francisco Bay Area

## Roche Molecular Systems

### Principal Clinical Research Associate

October 2015 - September 2017 (2 years)

Pleasanton, CA

## NeoTract

### Clinical & Regulatory Specialist

March 2011 - November 2013 (2 years 9 months)

*Acquired by Teleflex

## UCSF Medical Center

### Research Coordinator

April 2010 - February 2011 (11 months)

San Francisco Bay Area

## Education

### University of California, Berkeley

BA, Women's Health & Sexuality · (2004 - 2008)

### San Francisco State University

MA, Sexuality Studies · (2010 - 2012)

### Stanford University

Continuing Studies, Business and Consumer Brands · (2016)

Page 2 of 2

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** The Bloomi, Inc.

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 07-12-2017

**Physical Address:** 3987 First Street, Livermore, CA, 94551

**Issuer Website:** http://thebloomi.com

**Is there a Co-Issuer?:** Yes

**Intermediary Name:** Wefunder Portal LLC

**Intermediary CIK:** 0001670254

**Intermediary File Number:** 007-00033

**Intermediary CRD Number:** 283503

### Offering Information

**Compensation to Intermediary:** 4.0% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.

**Financial Interest in Issuer:** No

**Type of Security Offered:** Other

**Other Description of Security:** Simple Agreement for Future Equity (SAFE)

**Number of Securities Offered:** 100000

**Price per Security:** $1.00

**Method for Determining Price:** Pro-rated portion of the total principal value of $100,000; interests will be sold in increments of $1; each investment is convertible to one share of stock as described under Item 13.

**Target Offering Amount:** $100,000.00

**Oversubscription Accepted:** Yes

**Oversubscription Allocation Type:** Other

**Description of Oversubscription:** As determined by the issuer

**Maximum Offering Amount:** $618,000.00

**Deadline to Reach Target Amount:** 04-08-2023

### Annual Report Disclosure Requirements

**Current Number of Employees:** 5

**Total Assets (Most Recent Fiscal Year):** $494,107.00

**Total Assets (Prior Fiscal Year):** $30,322.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $133,310.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $3,416.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $157,376.00

**Short-Term Debt (Prior Fiscal Year):** $17,902.00

**Long-Term Debt (Most Recent Fiscal Year):** $450,658.00

**Long-Term Debt (Prior Fiscal Year):** $35,658.00

**Revenues/Sales (Most Recent Fiscal Year):** $227,369.00

**Revenues/Sales (Prior Fiscal Year):** $166,271.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $206,747.00

**Cost of Goods Sold (Prior Fiscal Year):** $131,869.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $-454,758.00

**Net Income (Prior Fiscal Year):** $-143,158.00

**Jurisdictions Offered:**

ALABAMA, ALASKA, ARIZONA, ARKANSAS, CALIFORNIA, COLORADO, CONNECTICUT, DELAWARE, DISTRICT OF COLUMBIA, FLORIDA, GEORGIA, HAWAII, IDAHO, ILLINOIS, INDIANA, IOWA, KANSAS, KENTUCKY, LOUISIANA, MAINE, MARYLAND, MASSACHUSETTS, MICHIGAN, MINNESOTA, MISSISSIPPI, MISSOURI, MONTANA, NEBRASKA, NEVADA, NEW HAMPSHIRE, NEW JERSEY, NEW MEXICO, NEW YORK, NORTH CAROLINA, NORTH DAKOTA, OHIO, OKLAHOMA, OREGON, PENNSYLVANIA, RHODE ISLAND, SOUTH CAROLINA, SOUTH DAKOTA, TENNESSEE, TEXAS, UTAH, VERMONT, VIRGINIA, WASHINGTON, WEST VIRGINIA, WISCONSIN, WYOMING, B5, GU, PR, VI, 1V

### Signatures

**Issuer:** The Bloomi, Inc.

**Signature:** Rebecca Alvarez Story

**Title:** Co-Founder and CEO

---

**Signature:** Julie Leclercq

**Title:** Co-Founder and CBO

**Date:** 03-03-2023

---

**Signature:** Rebecca Alvarez Story

**Title:** Co-Founder and CEO

**Date:** 03-03-2023